Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 48637 

Global Expedited Package Services 

(GEPS)—Non-Published Rates 12 

Priority Mail International Regional Rate 

Boxes—Non-Published Rates 

Outbound Competitive International 

Merchandise Return Service Agreement 

with Royal Mail Group, Ltd. 

Priority Mail International Regional Rate 

Boxes Contracts Priority Mail 

International Regional Rate Boxes 

Contracts 1 

Competitive International Merchandise 

Return Service Agreements with Foreign 

Postal Operators 

Competitive International Merchandise 

Return Service Agreements with Foreign 

Postal Operators 1 

Competitive International Merchandise 

Return Service Agreements with Foreign 

Postal Operators 2 

Alternative Delivery Provider (ADP) 

Contracts ADP 1 

Inbound International * 

International Business Reply Service 

(IBRS) Competitive Contracts 

International Business Reply Service 

Competitive Contract 1 

International Business Reply Service 

Competitive Contract 3 

Inbound Direct Entry Contracts with 

Customers 

Inbound Direct Entry Contracts with 

Foreign Postal Administrations 

Inbound Direct Entry Contracts with 

Foreign Postal Administrations 

Inbound Direct Entry Contracts with 

Foreign Postal Administrations 1 

Inbound EMS 

Inbound EMS 2 

Inbound Air Parcel Post (at non-UPU rates) 

Royal Mail Group Inbound Air Parcel Post 

Agreement 

Inbound Competitive Multi-Service 

Agreements with Foreign Postal 

Operators 

Inbound Competitive Multi-Service 

Agreements with Foreign Postal 

Operators 1 

Special Services * 

Address Enhancement Services 

Greeting Cards, Gift Cards, and Stationery 

International Ancillary Services 

International Money Transfer Service— 

Outbound 

International Money Transfer Service— 

Inbound 

Premium Forwarding Service 

Shipping and Mailing Supplies 

Post Office Box Service 

Competitive Ancillary Services 

Nonpostal Services * 

Advertising 

Licensing of Intellectual Property other 

than Officially Licensed Retail Products 

(OLRP) 

Mail Service Promotion 

Officially Licensed Retail Products (OLRP) 

Passport Photo Service 

Photocopying Service 

Rental, Leasing, Licensing or other NonSale Disposition of Tangible Property 

Training Facilities and Related Services 

USPS Electronic Postmark (EPM) Program 

Market Tests * 

Customized Delivery 

Global eCommerce Marketplace (GeM) 

Stacy L. Ruble, 

Secretary. 

[FR Doc. 2017–22645 Filed 10–18–17; 8:45 am] 

BILLING CODE 7710–FW–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

40 CFR Parts 9 and 721 

[EPA–HQ–OPPT–2017–0166; FRL–9964–42] 

RIN 2070–AB27 

Significant New Use Rules on Certain 

Chemical Substances 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Direct final rule. 

SUMMARY: EPA is promulgating 

significant new use rules (SNURs) under 

the Toxic Substances Control Act 

(TSCA) for 29 chemical substances 

which were the subject of 

premanufacture notices (PMNs). The 

chemical substances are subject to 

consent orders issued by EPA pursuant 

to section 5(e) of TSCA. This action 

requires persons who intend to 

manufacture (defined by statute to 

include import) or process any of these 

29 chemical substances for an activity 

that is designated as a significant new 

use by this rule to notify EPA at least 

90 days before commencing that 

activity. The required notification 

initiates EPA’s evaluation of the 

intended use within the applicable 

review period. Persons may not 

commence manufacture or processing 

for the significant new use until EPA 

has conducted a review of the notice, 

made an appropriate determination on 

the notice, and has taken such actions 

as are required with that determination. 

DATES: This rule is effective on 

December 18, 2017. For purposes of 

judicial review, this rule shall be 

promulgated at 1 p.m. (e.s.t.) on 

November 2, 2017. 

Written adverse or critical comments, 

or notice of intent to submit adverse or 

critical comments, on one or more of 

these SNURs must be received on or 

before November 20, 2017 (see Unit VI. 

of the SUPPLEMENTARY INFORMATION). If 

EPA receives written adverse or critical 

comments, or notice of intent to submit 

adverse or critical comments, on one or 

more of these SNURs before November 

20, 2017, EPA will withdraw the 

relevant sections of this direct final rule 

before its effective date. 

For additional information on related 

reporting requirement dates, see Units 

I.A., VI., and VII. of the SUPPLEMENTARY

INFORMATION. 

ADDRESSES: Submit your comments, 

identified by docket identification (ID) 

number EPA–HQ–OPPT–2017–0166, by 

one of the following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the online 

instructions for submitting comments. 

Do not submit electronically any 

information you consider to be 

Confidential Business Information (CBI) 

or other information whose disclosure is 

restricted by statute. 

• Mail: Document Control Office 

(7407M), Office of Pollution Prevention 

and Toxics (OPPT), Environmental 

Protection Agency, 1200 Pennsylvania 

Ave. NW., Washington, DC 20460–0001. 

• Hand Delivery: To make special 

arrangements for hand delivery or 

delivery of boxed information, please 

follow the instructions at http://

www.epa.gov/dockets/contacts.html. 

Additional instructions on 

commenting or visiting the docket, 

along with more information about 

dockets generally, is available at http:// 

www.epa.gov/dockets. 

FOR FURTHER INFORMATION CONTACT:

For technical information contact: 

Kenneth Moss, Chemical Control 

Division (7405M), Office of Pollution 

Prevention and Toxics, Environmental 

Protection Agency, 1200 Pennsylvania 

Ave. NW., Washington, DC 20460–0001; 

telephone number: (202) 564–9232; 

email address: moss.kenneth @epa.gov. 

For general information contact: The 

TSCA-Hotline, ABVI-Goodwill, 422 

South Clinton Ave., Rochester, NY 

14620; telephone number: (202) 554– 

1404; email address: TSCA-Hotline@

epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

You may be potentially affected by 

this action if you manufacture, process, 

or use the chemical substances 

contained in this rule. The following list 

of North American Industrial 

Classification System (NAICS) codes is 

not intended to be exhaustive, but rather 

provides a guide to help readers 

determine whether this document 

applies to them. Potentially affected 

entities may include: 

• Manufacturers or processors of one 

or more subject chemical substances 

(NAICS codes 325 and 324110), e.g., 

chemical manufacturing and petroleum 

refineries. 

This action may also affect certain 

entities through pre-existing import 

certification and export notification 


rmajette on DSKBCKNHB2PROD with RULES
48638 Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 

rules under TSCA. Chemical importers 

are subject to the TSCA section 13 (15 

U.S.C. 2612) import certification 

requirements promulgated at 19 CFR 

12.118 through 12.127 and 19 CFR 

127.28. Chemical importers must certify 

that the shipment of the chemical 

substance complies with all applicable 

rules and orders under TSCA. Importers 

of chemicals subject to these SNURs 

must certify their compliance with the 

SNUR requirements. The EPA policy in 

support of import certification appears 

at 40 CFR part 707, subpart B. In 

addition, pursuant to 40 CFR 721.20, 

any persons who export or intend to 

export a chemical substance that is the 

subject of this rule on or after November 

20, 2017 are subject to the export 

notification provisions of TSCA section 

12(b) (15 U.S.C. 2611(b)) and must 

comply with the export notification 

requirements in 40 CFR part 707, 

subpart D. 

B. What should I consider as I prepare 

my comments for EPA? 

1. Submitting CBI. Do not submit this 

information to EPA through 

regulations.gov or email. Clearly mark 

the part or all of the information that 

you claim to be CBI. For CBI 

information in a disk or CD–ROM that 

you mail to EPA, mark the outside of the 

disk or CD–ROM as CBI and then 

identify electronically within the disk or 

CD–ROM the specific information that 

is claimed as CBI. In addition to one 

complete version of the comment that 

includes information claimed as CBI, a 

copy of the comment that does not 

contain the information claimed as CBI 

must be submitted for inclusion in the 

public docket. Information so marked 

will not be disclosed except in 

accordance with procedures set forth in 

40 CFR part 2. 

2. Tips for preparing your comments. 

When preparing and submitting your 

comments, see the commenting tips at 

http://www.epa.gov/dockets/ 

comments.html. 

II. Background 

A. What action is the Agency taking? 

EPA is promulgating these SNURs 

using direct final procedures. These 

SNURs will require persons to notify 

EPA at least 90 days before commencing 

the manufacture or processing of a 

chemical substance for any activity 

designated by these SNURs as a 

significant new use. Receipt of such 

notices allows EPA to assess risks that 

may be presented by the intended uses 

and, if appropriate, to regulate the 

proposed use before it occurs. 

Additional rationale and background to 

these rules are more fully set out in the 

preamble to EPA’s first direct final 

SNUR published in the Federal Register 

issue of April 24, 1990 (55 FR 17376). 

Consult that preamble for further 

information on the objectives, rationale, 

and procedures for SNURs and on the 

basis for significant new use 

designations, including provisions for 

developing test data. 

B. What is the Agency’s authority for 

taking this action? 

Section 5(a)(2) of TSCA (15 U.S.C. 

2604(a)(2)) authorizes EPA to determine 

that a use of a chemical substance is a 

‘‘significant new use.’’ EPA must make 

this determination by rule after 

considering all relevant factors, 

including the four bulleted TSCA 

section 5(a)(2) factors listed in Unit III. 

Once EPA determines that a use of a 

chemical substance is a significant new 

use, TSCA section 5(a)(1)(B)(i) (15 

U.S.C. 2604(a)(1)(B)(i)) requires persons 

to submit a significant new use notice 

(SNUN) to EPA at least 90 days before 

they manufacture or process the 

chemical substance for that use. TSCA 

prohibits such manufacturing or 

processing from commencing until EPA 

has conducted a review of the notice, 

made an appropriate determination on 

the notice, and taken such actions as are 

required in association with that 

determination (15 U.S.C. 

2604(a)(1)(B)(ii)). As described in Unit 

V., the general SNUR provisions are 

found at 40 CFR part 721, subpart A. 

C. Applicability of General Provisions 

General provisions for SNURs appear 

in 40 CFR part 721, subpart A. These 

provisions describe persons subject to 

the rule, recordkeeping requirements, 

exemptions to reporting requirements, 

and applicability of the rule to uses 

occurring before the effective date of the 

rule. Provisions relating to user fees 

appear at 40 CFR part 700. Pursuant to 

§ 721.1(c), persons subject to these 

SNURs must comply with the same 

SNUN requirements and EPA regulatory 

procedures as submitters of PMNs under 

TSCA section 5(a)(1)(A) (15 U.S.C. 

2604(a)(1)(A)). In particular, these 

requirements include the information 

submission requirements of TSCA 

sections 5(b) and 5(d)(1) (15 U.S.C. 

2604(b) and 2604(d)(1)), the exemptions 

authorized by TSCA sections 5(h)(1), 

5(h)(2), 5(h)(3), and 5(h)(5) (15 U.S.C. 

2604(h)(1), 2604(h)(2), 2604(h)(3), and 

2604(h)(5)), and the regulations at 40 

CFR part 720. Once EPA receives a 

SNUN, EPA must either determine that 

the significant new use is not likely to 

present an unreasonable risk of injury or 

take such regulatory action as is 

associated with an alternative 

determination before the manufacture or 

processing for the significant new use 

can commence. If EPA determines that 

the significant new use is not likely to 

present an unreasonable risk, EPA is 

required under TSCA section 5(g) (15 

U.S.C. 2604(g)) to make public, and 

submit for publication in the Federal 

Register, a statement of EPA’s findings. 

III. Significant New Use Determination 

Section 5(a)(2) of TSCA states that 

EPA’s determination that a use of a 

chemical substance is a significant new 

use must be made after consideration of 

all relevant factors, including: 

• The projected volume of 

manufacturing and processing of a 

chemical substance. 

• The extent to which a use changes 

the type or form of exposure of human 

beings or the environment to a chemical 

substance. 

• The extent to which a use increases 

the magnitude and duration of exposure 

of human beings or the environment to 

a chemical substance. 

• The reasonably anticipated manner 

and methods of manufacturing, 

processing, distribution in commerce, 

and disposal of a chemical substance. 

In addition to these factors 

enumerated in TSCA section 5(a)(2), the 

statute authorized EPA to consider any 

other relevant factors. 

To determine what would constitute a 

significant new use for the 37 chemical 

substances that are the subject of these 

SNURs, EPA considered relevant 

information about the toxicity of the 

chemical substances, likely human 

exposures and environmental releases 

associated with possible uses, and the 

four bulleted TSCA section 5(a)(2) 

factors listed in this unit. 

IV. Substances Subject to This Rule 

EPA is establishing significant new 

use and recordkeeping requirements for 

29 chemical substances in 40 CFR part 

721, subpart E. In this unit, EPA 

provides the following information for 

each chemical substance: 

• PMN number. 

• Chemical name (generic name, if 

the specific name is claimed as CBI). 

• Chemical Abstracts Service (CAS) 

Registry number (if assigned for nonconfidential chemical identities). 

• Basis for the consent order under 

TSCA section 5(e) (15 U.S.C. 2604(e)). 

• Tests recommended by EPA to 

provide sufficient information to 

evaluate the chemical substance (see 

Unit VIII. for more information). 

• CFR citation assigned in the 

regulatory text section of this rule. 

The regulatory text section of this rule 

specifies the activities designated as 


rmajette on DSKBCKNHB2PROD with RULES
Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 48639 

significant new uses. Certain new uses, 

including production volume limits 

(i.e., limits on manufacture volume) and 

other uses designated in this rule, may 

be claimed as CBI. Unit IX. discusses a 

procedure companies may use to 

ascertain whether a proposed use 

constitutes a significant new use. 

This rule includes 29 PMN substances 

that are subject to ‘‘risk-based’’ consent 

orders under TSCA section 

5(e)(1)(A)(ii)(I) (15 U.S.C. 

2604(e)(1)(A)(ii)(I)) where EPA 

determined that activities associated 

with the PMN substances may present 

unreasonable risk to human health or 

the environment. Those consent orders 

require protective measures to limit 

exposures or otherwise mitigate the 

potential unreasonable risk. The SNURs 

are promulgated pursuant to § 721.160, 

and are based on and consistent with 

the provisions in the underlying consent 

orders. The SNURs designate as a 

‘‘significant new use’’ the absence of the 

protective measures required in the 

corresponding consent orders. 

Where EPA determined that the PMN 

substance may present an unreasonable 

risk of injury to human health via 

inhalation exposure, the underlying 

TSCA section 5(e) consent order usually 

requires, among other things, that 

potentially exposed employees wear 

specified respirators unless actual 

measurements of the workplace air 

show that air-borne concentrations of 

the PMN substance are below a New 

Chemical Exposure Limit (NCEL) that is 

established by EPA to provide adequate 

protection to human health. In addition 

to the actual NCEL concentration, the 

comprehensive NCELs provisions in 

TSCA section 5(e) consent orders, 

which are modeled after Occupational 

Safety and Health Administration 

(OSHA) Permissible Exposure Limits 

(PELs) provisions, include requirements 

addressing performance criteria for 

sampling and analytical methods, 

periodic monitoring, respiratory 

protection, and recordkeeping. 

However, no comparable NCEL 

provisions currently exist in 40 CFR 

part 721, subpart B, for SNURs. 

Therefore, for these cases, the 

individual SNURs in 40 CFR part 721, 

subpart E, will state that persons subject 

to the SNUR who wish to pursue NCELs 

as an alternative to the § 721.63 

respirator requirements may request to 

do so under § 721.30. EPA expects that 

persons whose requests under § 721.30 

to use the NCELs approach for SNURs 

are approved by EPA will be required to 

comply with NCELs provisions that are 

comparable to those contained in the 

corresponding TSCA section 5(e) 

consent order for the same chemical 

substance. 

PMN Number: P–15–310 

Chemical name: 1,2,4- 

Benzenetricarboxylic acid, mixed decyl 

and octyl triesters. 

CAS number: Not available. 

Effective date of TSCA section 5(e) 

consent order: January 31, 2017. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the PMN 

substance will be used as a lubricant in 

special chain oils for conveyor belts. 

Based on submitted test data, EPA 

predicts blood and adrenal gland effects 

to unprotected workers from repeated 

dermal exposures. EPA also predicts 

endocrine disruption based on Structure 

Activity Relationship (SAR) analysis on 

analogous phthalates. The Order was 

issued under TSCA sections 

5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), 

based on a finding that the substance 

may present an unreasonable risk of 

injury to human health. To protect 

against these risks, the consent order 

requires: 

1. Use of personal protective 

equipment to prevent dermal exposure. 

2. Not use, formulate, or distribute for 

use other than as stated in the PMN. 

3. No manufacture beyond an annual 

production volume of 150,000 kg. 

Recommended testing: EPA has 

determined that the results of certain 

human health toxicity testing would 

help characterize the PMN substance. 

The submitter has agreed not to exceed 

the confidential production limit 

without performing an Extended OneGeneration Reproductive Toxicity Study 

(OECD Test Guideline 443). 

CFR citation: 40 CFR 721.10996. 

PMN Numbers: P–15–487, P–15–488, P– 

15–489, P–15–490, and P–15–491 

Chemical names: Multi-walled carbon 

nanotubes (generic). 

CAS numbers: Not available. 

Effective date of TSCA section 5(e) 

consent order: February 17, 2017. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the PMN 

substances will be used as additives for 

electro-static discharge (ESD) in 

electronic devices, electronics, and 

materials; additives for weight reduction 

in materials; additives to improve 

mechanical properties or electrical 

conductivities; heat-generating elements 

in heating devices and materials; 

additives for heat transfer and thermal 

emissions in electronic devices and 

materials; semi-conductor, conductive, 

or resistive elements in electronic 

circuitry and devices; additives to 

improve conductivity in electronic 

circuitry, energy storage systems, and 

devices; electron emitters for lighting 

and x-ray sources; additive for 

electromagnetic interface shielding in 

electronic devices; additives for 

electrodes in electronic materials and 

electronic devices; catalyst support in 

chemical manufacturing; coating 

additives to improve corrosion 

resistance or conductive properties; 

additives for fibers in structural and 

electrical applications; additives for 

fibers in fabrics and textiles; filter 

additives to remove nanoscale materials; 

semi-conducting compounding 

additives far high-voltage cable; and 

additives for super-hydrophobicity. A 

submitted 90-day inhalation toxicity 

study for P–15–487 demonstrated no 

effects at 1 mg/m3, which was the 

highest dose tested. Based on SAR 

analysis on analogous carbon nanotubes 

(CNT), EPA predicts pulmonary toxicity 

and oncogenicity to unprotected 

workers from repeated inhalation 

exposures. No ecotoxicity studies on 

CNT are available in which a broad 

range of production methods, sources, 

purification, functionalization, etc. were 

investigated. EPA expects that some 

fraction of the PMN substances, if 

released into the environment, will 

eventually become suspended in water. 

The Order was issued under TSCA 

sections 5(a)(3)(B)(ii)(I) and 

5(e)(1)(A)(ii)(I), based on a finding that 

the substances may present an 

unreasonable risk of injury to human 

health and the environment. To protect 

against these risks, the consent order 

requires: 

1. Use of personal protective 

equipment to prevent dermal exposure 

and a NIOSH-certified respirator with 

N–100, P–100, or R–100 cartridges with 

an assigned protection factor (APF) of at 

least 50 (where there is a potential for 

inhalation exposure). 

2. Use of the PMN substances only for 

the uses specified in the consent order. 

3. No use in application methods that 

generate a dust, mist, or aerosol unless 

such application method occurs in an 

enclosed process. 

4. No use of the PMN substances 

resulting in releases to surface waters 

and disposal of the PMN substances 

only by landfill or incineration. 

Recommended testing: EPA has 

determined that a subchronic 90-day 

inhalation toxicity study (OPPTS 

870.3465 or OECD 413), a two-year 

inhalation bioassay (OPPTS 870.4200), a 

fish early-life stage toxicity test (OCSPP 

Test Guideline 850.1400), a daphnid 

chronic toxicity test (OCSPP Test 

Guideline 850.1300), and an algal 

toxicity test (OCSPP Test Guideline 

850.4500) would help characterize 

possible health and environmental 


rmajette on DSKBCKNHB2PROD with RULES
48640 Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 

effects of the substances. Although the 

Order does not require these tests, the 

Order’s restrictions on manufacture, 

processing, distribution in commerce, 

and disposal will remain in effect until 

the Order is modified or revoked by 

EPA based on submission of this or 

other relevant information. 

CFR citation: 40 CFR 721.10997. 

PMN Number: P–16–165 

Chemical name: Propanoic acid, iron 

(2+) salt (2:1). 

CAS number: 1952336–63–8. 

Effective date of TSCA section 5(e) 

consent order: February 15, 2017. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the PMN 

substance will be used as a component 

in a metal organic product that will be 

used in paint and ink driers, 

unsaturated polyester resins promoters, 

lube/grease additives, fuel additives, 

polymerization catalysts, and specialty 

petrochemical catalysts at less than 1 

percent. Based on submitted test data, 

EPA predicts liver and developmental 

toxicity to unprotected workers from 

repeated inhalation exposures. The 

Order was issued under TSCA sections 

5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), 

based on a finding that the substance 

may present an unreasonable risk of 

injury to human health. To protect 

against these risks, the consent order 

requires: 

1. Use of a NIOSH-certified respirator 

with an APF of at least 10 (where there 

is a potential for inhalation exposures). 

2. Establishment and use of a hazard 

communication program, including 

human health precautionary statements 

on each label and in the Safety Data 

Sheet (SDS). 

3. No manufacture beyond an annual 

production volume of 150,000 kg. 

4. Not process or use the PMN 

substance for non-industrial 

applications. 

5. Not process or use the PMN 

substance in formulations where the 

concentration is greater than 1%. 

Recommended testing: EPA has 

determined that the results of certain 

human health toxicity testing would 

help characterize the PMN substance. 

The submitter has agreed not to exceed 

the confidential production limit 

without performing the prenatal 

development toxicity study (OECD 414). 

In addition, EPA has determined that 

the results of a combined chronic 

toxicity and carcinogenicity toxicity test 

(OPPTS 870.4300) would help 

characterize the health effects of the 

PMN substance. The Order’s restrictions 

on manufacture, processing, distribution 

in commerce, and disposal will remain 

in effect until the Order is modified or 

revoked by EPA based on submission of 

this or other relevant information. 

CFR citation: 40 CFR 721.10998. 

PMN Numbers: P–16–255, P–16–256, 

P–16–257, P–16–258, and P–16–259 

Chemical names: 1-Butanaminium, 

N,N,N-tributyl-, carbonic acid (1:1) (P– 

16–255), 1-Butanaminium, N,N,Ntributyl-, methyl carbonate (1:1) (P–16– 

256), 1-Butanaminium, N,N,N-tributyl-, 

ethyl carbonate (1:1) (P–16–257), 1- 

Butanaminium, N,N,N-tributyl-, propyl 

carbonate (1:1) (P–16–258), 1- 

Butanaminium, N,N,N-tributyl-, and 1- 

methylethyl carbonate (1:1) (P–16–259) 

CAS numbers: 17351–62–1(P–16– 

255), 56294–05–2(P–16–256), 478796– 

04–2(P–16–257), 1338579–13–7(P–16– 

258), and 1803407–49–9(P–16–259) 

Effective date of TSCA section 5(e) 

consent order: March 7, 2017. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the PMN 

substances will be used as blocked 

catalysts for paints and coatings. Based 

on submitted test data, EPA predicts 

strong irritation to the skin, eyes, and 

mucous membranes as well as acute 

toxicity and corrosivity-related 

neurotoxicity from repeated dermal and 

inhalation exposures. Further, based on 

test data on the PMN substances, EPA 

predicts toxicity to aquatic organisms 

may occur at concentrations that exceed 

34 parts per billion (ppb) of the PMN 

substances in surface waters. The Order 

was issued under TSCA sections 

5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), 

based on a finding that the substances 

may present an unreasonable risk of 

injury to human health and the 

environment. To protect against these 

risks, the consent order requires: 

1. Use of personal protective 

equipment to prevent dermal exposures. 

2. Establishment and use of a hazard 

communication program, including 

human health precautionary statements 

on each label and in a safety data sheet 

(SDS). 

3. Use of the PMN substances only for 

the use specified in the consent order. 

4. Use of the PMN substances at a 

concentration no greater than 1.5% by 

weight in the final product. 

Recommended testing: EPA has 

determined that the results of certain 

environmental toxicity testing would 

help characterize the PMN substances. 

The submitter has agreed not to exceed 

the confidential production limit 

without performing a daphnid chronic 

toxicity test (OCSPP 850.1300). 

CFR citations: 40 CFR 721.10999 (P– 

16–255), 40 CFR 721.11000 (P–16–256), 

40 CFR 721.11001 (P–16–257), 40 CFR 

721.11002 (P–16–258), and 40 CFR 

721.11003 (P–16–259). 

PMN Number: P–16–284 

Chemical name: Anilino substituted 

bis-triazinyl derivative of 4,4′- 

diaminostilbene-2,2′-disulfonic acid, 

mixed amine sodium salt (generic). 

CAS number: Not available. 

Effective date of TSCA section 5(e) 

consent order: May 12, 2017. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the PMN 

substance will be used as an optical 

brightener for textiles, paper, and 

paperboard. Based on submitted test 

data, EPA predicts adrenal gland effects 

to unprotected workers from repeated 

dermal and inhalation exposures. The 

Order was issued under TSCA sections 

5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), 

based on a finding that the substance 

may present an unreasonable risk of 

injury to human health. To protect 

against these risks, the consent order 

requires: 

(1) Import only of the PMN substance 

as a solution. 

(2) Use only as an optical brightener 

for textiles, paper and paperboard. 

(3) No use of the PMN substance in 

application methods that generate a 

dust, mist, or aerosol unless such 

application method occurs in an 

enclosed process. 

(4) Non industrial use only where the 

PMN substance is not sold for 

‘‘consumer use’’ or for ‘‘commercial 

uses’’ (as the term is defined in § 721.3) 

when the ‘‘saleable goods or service’’ 

could introduce PMN material into a 

‘‘consumer’’ setting (as that term is 

defined in § 721.3). 

Recommended testing: EPA has 

determined that the results of physical/ 

chemistry testing would help 

characterize the PMN substance. The 

submitter has agreed not to manufacture 

beyond a certain time period without 

measuring the particle size distribution 

to characterize the particle size 

distribution of fractions less than 10 

microns of the dry particle PMN 

substance. In addition, EPA has 

determined that the results of a 90-day 

subchronic inhalation toxicity study 

(OPPTS 870.3465 or OECD 413) would 

help characterize the health effects of 

the PMN substance. The Order’s 

restrictions on manufacture, processing, 

distribution in commerce, and disposal 

will remain in effect until the Order is 

modified or revoked by EPA based on 

submission of this or other relevant 

information. 

CFR citation: 40 CFR 721.11004. 

PMN Numbers: P–16–309 and P–16–310 

Chemical names: 12-Hydroxystearic 

acid, reaction products with alkylene 

diamine and alkanoic acid (generic). 


rmajette on DSKBCKNHB2PROD with RULES
Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 48641 

CAS numbers: Not available. 

Effective date of TSCA section 5(e) 

consent order: February 17, 2017. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the PMN 

substances will be used as rheological or 

thixotropic agents used in the 

production of solvent based industrial 

coatings, high solid aromatic paints, 

adhesives, sealants, and other types of 

paints and topcoats. Based on submitted 

test data, EPA predicts blood and 

hematology effects. Further, based on 

SAR analysis of test data on analogous 

amides, EPA predicts toxicity to aquatic 

organisms may occur at concentrations 

that exceed 2 ppb of the PMN 

substances in surface waters. The Order 

was issued under TSCA sections 

5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), 

based on a finding that the substances 

may present an unreasonable risk of 

injury to human health and the 

environment. To protect against these 

risks, the consent order requires: 

(1) No domestic manufacture of the 

PMN substances. 

(2) No manufacture beyond the 

annual production volume specified in 

the consent order. 

(3) Use of the PMN substances only 

for the use specified in the consent 

order. 

(4) Compliance with the release to 

water provisions. 

Recommended testing: EPA has 

determined that the results of certain 

human health and environmental 

toxicity testing would help characterize 

the PMN substances. The submitter has 

agreed not to exceed the confidential 

production limit without performing a 

fish early-life stage toxicity test (OCSPP 

Test Guideline 850.1400), a daphnid 

chronic toxicity test (OCSPP Test 

Guideline 850.1300), and an algal 

toxicity test (OCSPP Test Guideline 

850.1300). In addition, EPA has 

determined that the results of a repeated 

dose dermal toxicity test (OPPTS Test 

Guideline 870.3200) would help 

characterize the human health effects of 

the PMN substances. The Order’s 

restrictions on manufacture, processing, 

distribution in commerce, and disposal 

will remain in effect until the Order is 

modified or revoked by EPA based on 

submission of this or other relevant 

information. 

CFR citation: 40 CFR 721.11005. 

PMN Number: P–16–315 

Chemical name: Alkyldiene, polymer, 

hydroxy terminated 

alkoxysilylalkylcarbamate (generic). 

CAS number: Not available. 

Effective date of TSCA section 5(e) 

consent order: January 17, 2017. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the PMN 

substance will be used as an additive to 

improve the compatibility of the 

dispersibility of inorganic fillers in 

industrial rubber formulation. Based on 

physical/chemical properties, EPA 

predicts irritation and lung effects to 

unprotected workers from repeated 

inhalation and dermal exposures. The 

Order was issued under TSCA sections 

5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), 

based on a finding that the substance 

may present an unreasonable risk of 

injury to human health. To protect 

against these risks, the consent order 

requires: 

(1) No domestic manufacture of the 

PMN substance. 

(2) Use of the PMN substance only for 

the use specified in the consent order. 

Recommended testing: EPA has 

determined that a 90-day subchronic 

inhalation test in rodents (OCSPP 

Harmonized Test Guideline 870.3465); 

would help characterize possible health 

effects of the substance. Although the 

Order does not require this test, the 

Order’s restrictions on manufacture, 

processing, distribution in commerce, 

and disposal will remain in effect until 

the Order is modified or revoked by 

EPA based on submission of this or 

other relevant information. 

CFR citation: 40 CFR 721.11006. 

PMN Number: P–16–323 

Chemical name: Alkylaldehyde, 

reaction products with substituted 

carbomonocycle-substituted 

heteromonocycle-alkylene glycol 

bis[[[[substituted(oxoneoalkyl)oxy]alkyl] 

amino]alkyl] ether polymer and alkyl 

substituted alkanediamine, acetate salts 

(generic). 

CAS number: Not available. 

Effective date of TSCA section 5(e) 

consent order: November 22, 2016. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the PMN 

substance will be used as a coating 

resin. Based on test data on 

formaldehyde and analogous cationic 

polymers, EPA predicts sensitization, 

carcinogenicity, and lung effects to 

unprotected workers from repeated 

dermal exposures. Further, based on 

SAR analysis of test data on analogous 

cationic polymers, EPA predicts toxicity 

to aquatic organisms may occur at 

concentrations that exceed 32 ppb of the 

PMN substance in surface waters. The 

Order was issued under TSCA sections 

5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), 

based on a finding that the substance 

may present an unreasonable risk of 

injury to human health and the 

environment. To protect against these 

risks, the consent order requires: 

(1) No manufacture of the PMN such 

that residual formaldehyde is more than 

0.1 weight percent of the PMN 

substance. 

(2) Establishment and use of a hazard 

communication program, including 

human health precautionary statements 

on each label and in the SDS. 

(3) Use of the PMN substance only for 

the use specified in the consent order. 

(4) No application method that 

generates a dust, mist, or aerosol. 

Recommended testing: EPA has 

determined that a 28-day subacute 

inhalation toxicity study (OECD 412), a 

fish acute toxicity test mitigated by 

humic acid (OCSPP Test Guideline 

850.1085), an aquatic invertebrate, acute 

toxicity test, freshwater daphnids 

(OCSPP Test Guideline 850.1075), and 

an algal toxicity test (OCSPP Test 

Guideline 850.4500) would help 

characterize possible health and 

environmental effects of the substance. 

Although the Order does not require 

these tests, the Order’s restrictions on 

manufacture, processing, distribution in 

commerce, and disposal will remain in 

effect until the Order is modified or 

revoked by EPA based on submission of 

this or other relevant information. 

CFR citation: 40 CFR 721.11007. 

PMN Numbers: P–16–330 and P–16–331 

Chemical names: Hydroxy functional 

triglyceride polymer with glycerol 

mono-ester and 1,1′-methylenebis[4- 

isocyanatobenzene] (P–16–330) and 

Hydroxy functional triglyceride polymer 

with glycerol mono-ester and 1,1′- 

methylenebis[isocyanatobenzene] (P– 

16–331) (generic) 

CAS numbers: Not available 

Effective date of TSCA section 5(e) 

consent order: February 14, 2017. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the PMN 

substances will be used as industrial 

adhesives. Based on submitted test data, 

EPA predicts dermal sensitization, 

respiratory sensitization, and lung 

effects to unprotected workers from 

repeated inhalation and dermal 

exposures. The Order was issued under 

TSCA sections 5(a)(3)(B)(ii)(I) and 

5(e)(1)(A)(ii)(I), based on a finding that 

the substances may present an 

unreasonable risk of injury to human 

health. To protect against these risks, 

the consent order requires: 

(1) Manufacture of the PMN 

substances to contain no more than 

0.1% residual isocyanate by weight. 

(2) No sale of the PMN substances for 

‘‘consumer use’’ or for ‘‘commercial 

uses’’ (as the term is defined in § 721.3) 

when the ‘‘saleable goods or service’’ 

could introduce PMNs material into a 


rmajette on DSKBCKNHB2PROD with RULES
48642 Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 

‘‘consumer’’ setting (as that term is 

defined in § 721.3). 

(3) Establishment and use of a hazard 

communication program, including 

human health precautionary statements 

on each label and in the SDS. 

Recommended testing: EPA has 

determined that a skin sensitization 

study (OPPTS 870.2600) and a 90-day 

inhalation study (OPPTS 870.3465) 

would help characterize possible health 

effects of the substances. Although the 

Order does not require these tests, the 

Order’s restrictions on manufacture, 

processing, distribution in commerce, 

and disposal will remain in effect until 

the Order is modified or revoked by 

EPA based on submission of this or 

other relevant information. 

CFR citations: 40 CFR 721.11008 (P– 

16–330) and 40 CFR 721.11009 (P–16– 

331). 

PMN Number: P–16–360 

Chemical name: Poly(oxy-1,2- 

ethanediyl),.alpha.-(1-oxodocosyl)- 

.omega.-[(1-oxodocosyl)oxy]-. 

CAS number: 36493–27–3. 

Effective date of TSCA section 5(e) 

consent order: December 12, 2016. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the PMN 

substance will be used as a fuel 

additive. Based on physical/chemical 

properties, EPA estimates the PMN 

substance would have low 

environmental hazard due to its poor 

water solubility. However, if the number 

of repeating ethylene oxide units in the 

polymer is large (i.e., greater than 10), 

the polymer would become a dispersible 

surfactant. Based on SAR analysis of test 

data on an analogous nonionic polymer, 

EPA predicts toxicity to aquatic 

organisms may occur at concentrations 

that exceed 350 ppb of the PMN 

substance in surface waters. The Order 

was issued under TSCA sections 

5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), 

based on a finding that the substance 

may present an unreasonable risk of 

injury to the environment. To protect 

against these risks, the consent order 

requires manufacture such that no more 

than 33% of the PMN substance 

contains 10 or more repeating ethylene 

oxide units. 

Recommended testing: EPA has 

determined that an acute invertebrate 

toxicity test, freshwater daphnids 

(OCSPP Test Guideline 850.1010), a fish 

acute toxicity test, freshwater and 

marine (OCSPP Test Guideline 

850.1075), a fish early-life stage toxicity 

test (OCSPP Test Guideline 850.1400), a 

daphnid chronic toxicity test (OCSPP 

Test Guideline 850.1300), and an algal 

toxicity test (OCSPP Test Guideline 

850.4500) would help characterize 

possible environmental effects of the 

substance. Although the Order does not 

require these tests, the Order’s 

restrictions on manufacture, processing, 

distribution in commerce, and disposal 

will remain in effect until the Order is 

modified or revoked by EPA based on 

submission of this or other relevant 

information. 

CFR citation: 40 CFR 721.11010. 

PMN Number: P–16–361 

Chemical name: Pulp, cellulose, 

reaction products with lignin. 

CAS number: 1671062–70–6. 

Effective date of TSCA section 5(e) 

consent order: December 12, 2016. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the PMN 

substance will be used as plastic 

reinforcement. Based on SAR analysis 

on structurally similar respirable poorly 

soluble particulates, EPA predicts 

pulmonary toxicity to unprotected 

workers from repeated inhalational 

exposures. The Order was issued under 

TSCA sections 5(a)(3)(B)(ii)(I) and 

5(e)(1)(A)(ii)(I), based on a finding that 

the substance may present an 

unreasonable risk of injury to human 

health. To protect against these risks, 

the consent order requires: 

(1) Distribution of the PMN substance 

only in a liquid or gel formulation, 

unless the solid particle form has a 

particle size distribution where less 

than 0.5% of the particles are less than 

10 microns. 

(2) No use in application methods that 

generate a dust, mist, or aerosol unless 

such application method occurs in an 

enclosed process. 

Recommended testing: EPA has 

determined that the results of physical/ 

chemical characteristics would help 

characterize the PMN substance. The 

submitter has agreed not to manufacture 

beyond a certain time period without 

measuring the particle size distribution 

to characterize the particle size 

distribution of fractions less than 10 

microns of the dry particle PMN 

substance. 

CFR citation: 40 CFR 721.11011. 

PMN Numbers: P–16–365 and P–16–367 

Chemical names: Alkyl carbonate, 

polymer with, substituted alkanes and 

substituted heteromonocycle, 

substituted alkyl acrylate-blocked 

(generic) (P–16–365) and substituted 

heteromonocycle, polymer with 

substituted alkane and ethoxylated 

alkane, substituted heteromonocycle 

substituted alkyl ester-blocked (generic) 

(P–16–367). 

CAS numbers: Not available. 

Effective date of TSCA section 5(e) 

consent order: January 3, 2017. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the PMN 

substances will be used as a UV curable 

coating resin for industrial use. Based 

on SAR analysis on structurally similar 

diisocyanates and acrylates, EPA 

predicts eye and skin irritation, dermal 

sensitization, respiratory sensitization, 

lung effects, mutagenicity, cancer, 

developmental, liver, and kidney 

toxicity to unprotected workers from 

repeated inhalation and dermal 

exposures. The Order was issued under 

TSCA sections 5(a)(3)(B)(ii)(I) and 

5(e)(1)(A)(ii)(I), based on a finding that 

the substances may present an 

unreasonable risk of injury to human 

health. To protect against these risks, 

the consent order requires: 

(1) Use of personal protective 

equipment involving impervious gloves 

(where there is a potential for dermal 

exposure). 

(2) Establishment and use of a hazard 

communication program, including 

human health precautionary statements 

on each label and in the SDS. 

(3) No manufacture, process, or use of 

the substances as consumer products. 

(4) Manufacture of the PMN 

substances to contain no more than 0.1 

residual isocyanate by weight. 

Recommended testing: EPA has 

determined that the results of a local 

lymph node assay (OPPTS 870.2600), a 

90-day inhalation toxicity test with 60- 

day holding period (OPPTS 870.3465), 

and a two-year oral bioassay (OPPTS 

870.4200) would help characterize 

possible health effects of the substances. 

Although the Order does not require 

these tests, the Order’s restrictions on 

manufacture, processing, distribution in 

commerce, and disposal will remain in 

effect until the Order is modified or 

revoked by EPA based on submission of 

this or other relevant information. 

CFR citations: 40 CFR 721.11012 (P– 

16–365) and 40 CFR 721.11013 (P–16– 

367). 

PMN Number: P–16–369 

Chemical name: Substituted 

heteromonocycle, telomer with 

substituted carbomonocycles, 

substituted alkyl ester (generic). 

CAS number: Not available. 

Effective date of TSCA section 5(e) 

consent order: January 23, 2017. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the PMN 

substance will be used as a UV curable 

coating resin for industrial use. Based 

on SAR analysis on structurally similar 

acrylates and other chemicals, EPA 

predicts eye and skin irritation, dermal 

sensitization, respiratory sensitization, 

lung effects, mutagenicity, cancer, 

developmental toxicity, liver, and 


rmajette on DSKBCKNHB2PROD with RULES
Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 48643 

kidney toxicity to unprotected workers 

from repeated inhalation and dermal 

exposures. The Order was issued under 

TSCA sections 5(a)(3)(B)(ii)(I) and 

5(e)(1)(A)(ii)(I), based on a finding that 

the substance may present an 

unreasonable risk of injury to human 

health. To protect against these risks, 

the consent order requires: 

(1) Use of personal protective 

equipment involving impervious gloves 

and protective clothing (where there is 

a potential for dermal exposure) and a 

NIOSH-certified respirator with an APF 

of at least 50 (where there is a potential 

for inhalation exposure). 

(2) No manufacture, process, or use of 

the substance for use in a consumer 

product. 

(3) Establishment and use of a hazard 

communication program, including 

human health precautionary statements 

on each label and in the SDS. 

(4) Manufacture of the PMN substance 

to contain no more than 0.1 residual by 

weight of chemicals described in the 

5(e) consent order. 

Recommended testing: EPA has 

determined that the results of certain 

human health toxicity testing would 

help characterize the PMN substance. 

The submitter has agreed not to exceed 

the confidential production limit 

without performing a 90-day inhalation 

toxicity test (OPPTS Test Guideline 

870.3465 or OECD Test Guideline 413). 

In addition, EPA has determined that 

the results of a skin sensitization 

(OPPTS 870.2600), a local lymph node 

assay (OECD 429), and two-year 

bioassay (oral) (OPPTS 870.4200) would 

help characterize possible health effects 

of the substance. Although the Order 

does not require these tests, the Order’s 

restrictions on manufacture, processing, 

distribution in commerce, and disposal 

will remain in effect until the Order is 

modified or revoked by EPA based on 

submission of this or other relevant 

information. 

CFR citation: 40 CFR 721.11014. 

PMN Number: P–16–387 

Chemical name: Aliphatic 

polycarboxylic acid, polymer with 

alicyclic polyhydric alcohol and 

polyoxyalkylene (generic). 

CAS number: Not available. 

Effective date of TSCA section 5(e) 

consent order: February 7, 2017. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the PMN 

substance will be used as an additive for 

a polymer. Based on physical/chemical 

properties of the PMN substance, EPA 

predicts lung effects to unprotected 

workers from repeated exposures. The 

Order was issued under TSCA sections 

5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), 

based on a finding that the substance 

may present an unreasonable risk of 

injury to human health. To protect 

against these risks, the consent order 

requires: 

(1) Manufacture of the PMN substance 

such that the minimum average 

molecular weight is 18,000 daltons. 

(2) No processing or use in any 

manner or method that generates a dust, 

mist, or aerosol. 

(3) Establishment and use of a hazard 

communication program, including 

human health precautionary statements 

on each label and in the SDS. 

Recommended testing: EPA has 

determined that the results of a 90-day 

inhalation toxicity test with 30-day 

holding period (OPPTS 870.3465), a 

combined repeated dose toxicity study 

with the reproduction/developmental 

toxicity screening test (OECD 422) an 

acute fish toxicity test (OCSPP 

850.1075), an acute daphnia toxicity test 

(OCSPP 850.1300), and an algal toxicity 

test (OCSPP 850.4500) would help 

characterize possible health and 

environmental effects of the substance. 

Although the Order does not require 

these tests, the Order’s restrictions on 

manufacture, processing, distribution in 

commerce, and disposal will remain in 

effect until the Order is modified or 

revoked by EPA based on submission of 

this or other relevant information. 

CFR citation: 40 CFR 721.11015. 

PMN Number: P–16–398 

Chemical name: Di-ammonium dicarboxylate (generic). 

CAS number: Not available. 

Effective date of TSCA section 5(e) 

consent order: November 14, 2016. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the PMN 

substance will be used as a corrosion 

inhibitor. Based on test data on 

analogous anionic surfactants, EPA 

predicts eye and mucous membrane 

irritation and skin sensitization to 

unprotected workers from repeated 

dermal exposures. The Order was issued 

under TSCA sections 5(a)(3)(B)(ii)(I) and 

5(e)(1)(A)(ii)(I), based on a finding that 

the substance may present an 

unreasonable risk of injury to human 

health. To protect against these risks, 

the consent order requires: 

1. Use of personal protective 

equipment including impervious gloves 

and protective clothing to prevent 

dermal exposure. 

2. Use of the PMN substance only for 

the use specified in the consent order. 

3. Establishment and use of a hazard 

communication program, including 

human health precautionary statements 

on each label and in the SDS. 

Recommended testing: EPA has 

determined that the results of certain 

human health toxicity testing would 

help characterize the effects of the PMN 

substance. The submitter has agreed not 

to exceed the confidential production 

limit without performing three skin 

sensitization studies (OECD 442B), 

(OECD 442C), and (OECD 442D). 

CFR citation: 40 CFR 721.11016. 

PMN Number: P–16–455 

Chemical name: Sodium tungsten 

oxide. 

CAS number: Not available. 

Effective date of TSCA section 5(e) 

consent order: November 2, 2016. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the PMN 

substance will be used as a component 

of infrared absorption material. Based 

on SAR analysis on structurally similar 

respirable poorly soluble particulates, 

EPA predicts pulmonary toxicity and 

carcinogenicity to unprotected workers 

from repeated inhalation exposures. 

Further, based on test data on analogous 

tungsten oxide, EPA predicts toxicity to 

aquatic organisms may occur at 

concentrations that exceed 1 ppb of the 

PMN substance in surface waters. The 

Order was issued under TSCA sections 

5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), 

based on a finding that the substance 

may present an unreasonable risk of 

injury to human health and the 

environment. To protect against these 

risks, the consent order requires: 

1. Use of personal protective 

equipment to prevent dermal exposure. 

2. Use of a NIOSH-certified respirator 

with an APF of at least 1000 or 

compliance with a NCEL of 0.3 ppm as 

an 8-hour time-weighted average to 

prevent inhalation exposure. 

3. Establishment and use of a hazard 

communication program, including 

human health precautionary statements 

on each label and in the SDS. 

4. Use of the PMN substance only for 

the use specified in the consent order. 

5. No use in application methods that 

generate a dust, mist, or aerosol unless 

such application method occurs in an 

enclosed process. 

6. No use of the PMN substance 

resulting in releases to surface waters 

and disposal of the PMN substance only 

by landfill or incineration. 

Recommended testing: EPA has 

determined that the results of certain 

human health toxicity testing would 

help characterize the PMN substance. 

The submitter has agreed not to exceed 

the confidential production limit 

without performing a 90-day inhalation 

toxicity test (OPPTS Test Guideline 

870.3465 or OECD Test Guideline 413) 


rmajette on DSKBCKNHB2PROD with RULES
48644 Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 

and a two- year inhalation bioassay test 

(OPPTS 870.4200). 

CFR citation: 40 CFR 721.11017. 

PMN Number: P–16–503 

Chemical name: Fatty acids, tall-oil, 

polymers with alkanoic acid, 

substituted carbomonocycle, alkyl 

peroxide-initiated (generic). 

CAS number: Not available. 

Effective date of TSCA section 5(e) 

consent order: January 11, 2017. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the PMN 

substance will be used as a site-limited 

polymer intermediate for production of 

a deck stain coating resin additive. 

Based on physical/chemical properties, 

EPA predicts low health hazard for the 

PMN substance when it is manufactured 

as described in the PMN. However, if 

the chemical substance is manufactured 

with a lower molecular weight and a 

higher proportion of the acid 

component (i.e., greater than 20%), the 

PMN substance could cause 

developmental effects in unprotected 

workers from repeated dermal and 

inhalation exposures. Further, based on 

physical/chemical properties, EPA 

predicts low hazard for the PMN 

substance when it is manufactured as 

described in the PMN due to low water 

solubility. However, if the chemical 

substance is manufactured with a higher 

proportion of the acid component (i.e., 

greater than 20%), there is potential for 

aquatic toxicity. The Order was issued 

under TSCA sections 5(a)(3)(B)(ii)(I) and 

5(e)(1)(A)(ii)(I), based on a finding that 

the substance may present an 

unreasonable risk of injury to human 

health and the environment. To protect 

against these risks, the consent order 

requires: 

1. Manufacture of the PMN substance 

to have an average molecular weight no 

less than 1500 daltons. 

2. Manufacture of the PMN substance 

to have no more than 24% by weight of 

the acid component. 

3. Use of the PMN substance only as 

intermediate. 

Recommended testing: EPA has 

determined that a combined repeated 

dose toxicity study with the 

reproduction/developmental toxicity 

screening test (OECD 422), water 

solubility test, log Kow tests, a 

compositional/component analysis 

(certificate of analysis), a fish early-life 

stage toxicity test (OCSPP Test 

Guideline 850.1400), a daphnid chronic 

toxicity test (OCSPP Test Guideline 

850.1300), fish acute toxicity mitigated 

by humic acid (OCSPP Test Guideline 

850.1085), an aquatic invertebrate, acute 

toxicity test, freshwater daphnids 

(OCSPP Test Guideline 850.1075), and 

an algal toxicity test (OCSPP Test 

Guideline 850.4500) would help 

characterize the physical-chemical 

properties and possible health and 

environmental effects of the substance. 

Although the Order does not require 

these tests, the Order’s restrictions on 

manufacture, processing, distribution in 

commerce, and disposal will remain in 

effect until the Order is modified or 

revoked by EPA based on submission of 

this or other relevant information. 

CFR citation: 40 CFR 721.11018. 

PMN Number: P–16–591 

Chemical name: Alkyl bisphenol 

(generic). 

CAS number: Not available. 

Effective date of TSCA section 5(e) 

consent order: January 9, 2017. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the PMN 

substance will be used as a component 

of printing ink. Based on test data on 

bisphenol analogs, EPA predicts 

irritation to eyes, skin, lung, and 

mucous membranes; developmental, 

reproductive, liver and kidney 

toxicities; dermal sensitization; 

photosensitization; effects to the 

adrenals and other toxic effects 

associated with an endocrine disruption 

mode of action to unprotected workers 

from repeated dermal and inhalation 

exposures. Further, based on SAR 

analysis of test data on analogous 

phenols, EPA predicts toxicity to 

aquatic organisms may occur at 

concentrations that exceed 2 ppb of the 

PMN substance in surface waters. The 

Order was issued under TSCA sections 

5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), 

based on a finding that the substance 

may present an unreasonable risk of 

injury to human health and the 

environment. To protect against these 

risks, the consent order requires: 

1. Use of personal protective 

equipment including impervious gloves 

and protective clothing to prevent 

dermal exposure and a NIOSH-certified 

respirator with an APF of at least 10 to 

prevent inhalation exposure. 

2. Use of the PMN substance only for 

the use specified in the consent order. 

3. Establishment and use of a hazard 

communication program, including 

human health precautionary statements 

on each label and in the SDS. 

4. No use of the PMN substance 

resulting in releases to surface waters. 

Recommended testing: EPA has 

determined that the results of certain 

human health and environmental 

toxicity testing would help characterize 

the PMN substance. The submitter has 

agreed not to exceed the confidential 

production limit without performing the 

reproduction/developmental toxicity 

screening test (OECD 422). In addition, 

EPA has determined that the results of 

a fish early-life stage toxicity test 

(OCSPP Test Guideline 850.1400) and a 

daphnid chronic toxicity test (OCSPP 

Test Guideline 850.1300) would help 

characterize the environmental effects of 

the PMN substance. Although the Order 

does not require these tests, the Order’s 

restrictions on manufacture, processing, 

distribution in commerce, and disposal 

will remain in effect until the Order is 

modified or revoked by EPA based on 

submission of this or other relevant 

information. 

CFR citation: 40 CFR 721.11019. 

V. Rationale and Objectives of the Rule 

A. Rationale 

During review of the PMNs submitted 

for the chemical substances that are 

subject to these SNURs, EPA concluded 

that for all 29 chemical substances, 

regulation was warranted under TSCA 

section 5(e), pending the development 

of information sufficient to make 

reasoned evaluations of the health or 

environmental effects of the chemical 

substances. The basis for such findings 

is outlined in Unit IV. Based on these 

findings, TSCA section 5(e) consent 

orders requiring the use of appropriate 

exposure controls were negotiated with 

the PMN submitters. The SNUR 

provisions for these chemical 

substances are consistent with the 

provisions of the TSCA section 5(e) 

consent orders. These SNURs are 

promulgated pursuant to § 721.160 (see 

Unit VI.). 

B. Objectives 

EPA is issuing these SNURs for 

specific chemical substances which 

have undergone premanufacture review 

because the Agency wants to achieve 

the following objectives with regard to 

the significant new uses designated in 

this rule: 

• EPA will receive notice of any 

person’s intent to manufacture or 

process a TSCA Chemical Substance 

Inventory (TSCA Inventory) listed 

chemical substance for the described 

significant new use before that activity 

begins. 

• EPA will have an opportunity to 

review and evaluate data submitted in a 

SNUN before the notice submitter 

begins manufacturing or processing a 

listed chemical substance for the 

described significant new use. 

• EPA will be able to either determine 

that the prospective manufacture or 

processing is not likely to present an 

unreasonable risk, or to take necessary 

regulatory action associated with any 

other determination, before the 


rmajette on DSKBCKNHB2PROD with RULES
Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 48645 

described significant new use of the 

chemical substance occurs. 

• EPA will ensure that all 

manufacturers and processors of the 

same chemical substance that is subject 

to a TSCA section 5(e) consent order are 

subject to similar requirements. 

Issuance of a SNUR for a chemical 

substance does not signify that the 

chemical substance is listed on the 

TSCA Inventory. Guidance on how to 

determine if a chemical substance is on 

the TSCA Inventory is available on the 

Internet at http://www.epa.gov/opptintr/ 

existingchemicals/pubs/tscainventory/ 

index.html. 

VI. Direct Final Procedures 

EPA is issuing these SNURs as a 

direct final rule, as described in 

§ 721.160(c)(3). In accordance with 

§ 721.160(c)(3)(ii) the effective date of 

this rule is December 18, 2017 without 

further notice, unless EPA receives 

written adverse or critical comments, or 

notice of intent to submit adverse or 

critical comments before November 20, 

2017. 

If EPA receives written adverse or 

critical comments, or notice of intent to 

submit adverse or critical comments, on 

one or more of these SNURs before 

November 20, 2017, EPA will withdraw 

the relevant sections of this direct final 

rule before its effective date. EPA will 

then issue a proposed SNUR for the 

chemical substance(s) on which adverse 

or critical comments were received, 

providing a 30-day period for public 

comment. 

This rule establishes SNURs for a 

number of chemical substances. Any 

person who submits adverse or critical 

comments, or notice of intent to submit 

adverse or critical comments, must 

identify the chemical substance and the 

new use to which it applies. EPA will 

not withdraw a SNUR for a chemical 

substance not identified in the 

comment. 

VII. Applicability of the Significant 

New Use Designation 

To establish a significant new use, 

EPA must determine that the use is not 

ongoing. The chemical substances 

subject to this rule have undergone 

premanufacture review. In cases where 

EPA has not received a notice of 

commencement (NOC) and the chemical 

substance has not been added to the 

TSCA Inventory, no person may 

commence such activities without first 

submitting a PMN. Therefore, for 

chemical substances for which an NOC 

has not been submitted EPA concludes 

that the designated significant new uses 

are not ongoing. 

When chemical substances identified 

in this rule are added to the TSCA 

Inventory, EPA recognizes that, before 

the rule is effective, other persons might 

engage in a use that has been identified 

as a significant new use. However, 

TSCA section 5(e) consent orders have 

been issued for these chemical 

substances, and the PMN submitters are 

prohibited by the TSCA section 5(e) 

consent orders from undertaking 

activities which would be designated as 

significant new uses. The identities of 

19 of the 29 chemical substances subject 

to this rule have been claimed as 

confidential and EPA has received no 

post-PMN bona fide submissions (per 

§§ 720.25 and 721.11). Based on this, 

the Agency believes that it is highly 

unlikely that any of the significant new 

uses described in the regulatory text of 

this rule are ongoing. 

Therefore, EPA designates July 10, 

2017 (the date of public release/web 

posting of this rule) as the cutoff date for 

determining whether the new use is 

ongoing. This designation varies slightly 

from EPA’s past practice of designating 

the date of Federal Register publication 

as the date for making this 

determination. The objective of EPA’s 

approach has been to ensure that a 

person could not defeat a SNUR by 

initiating a significant new use before 

the effective date of the direct final rule. 

In developing this rule, EPA has 

recognized that, given EPA’s practice of 

now posting rules on its Web site a 

week or more in advance of Federal 

Register publication, this objective 

could be thwarted even before that 

publication. Thus, EPA has slightly 

modified its approach in this 

rulemaking and plans to follow this 

modified approach in future significant 

new use rulemakings. 

Persons who begin commercial 

manufacture or processing of the 

chemical substances for a significant 

new use identified as of that date would 

have to cease any such activity upon the 

effective date of the final rule. To 

resume their activities, these persons 

would have to first comply with all 

applicable SNUR notification 

requirements and wait until the notice 

review period, including any 

extensions, expires. If such a person met 

the conditions of advance compliance 

under § 721.45(h), the person would be 

considered exempt from the 

requirements of the SNUR. Consult the 

Federal Register document of April 24, 

1990 for a more detailed discussion of 

the cutoff date for ongoing uses. 

VIII. Development and Submission of 

Information 

EPA recognizes that TSCA section 5 

does not require developing any 

particular new information (e.g., 

generating test data) before submission 

of a SNUN. There is an exception: TSCA 

section 5(b)(1) requires development of 

test data where the chemical substance 

subject to the SNUR is also subject to a 

rule, order or consent agreement under 

TSCA section 4 (15 U.S.C. 2603). 

In the absence of a rule order, or 

consent agreement under TSCA section 

4 covering the chemical substance, 

persons are required only to submit 

information in their possession or 

control and to describe any other 

information known to or reasonably 

ascertainable by them (see § 720.50). 

However, upon review of PMNs and 

SNUNs, the Agency has the authority to 

require appropriate testing. Unit IV. lists 

required or recommended testing for all 

of the listed SNURs. Descriptions of 

tests are provided for informational 

purposes. EPA strongly encourages 

persons, before performing any testing, 

to consult with the Agency pertaining to 

protocol selection. To access the OCSPP 

test guidelines referenced in this 

document electronically, please go to 

http://www.epa.gov/ocspp and select 

‘‘Test Methods and Guidelines.’’ The 

Organisation for Economic Co-operation 

and Development (OECD) test 

guidelines are available from the OECD 

Bookshop at http://

www.oecdbookshop.org or SourceOECD 

at http://www.sourceoecd.org. 

In the TSCA section 5(e) consent 

orders for the chemical substances 

regulated under this rule, EPA has 

established production volume limits in 

view of the lack of data on the potential 

health and environmental risks that may 

be posed by the significant new uses or 

increased exposure to the chemical 

substances. These limits cannot be 

exceeded unless the PMN submitter first 

submits the results of tests specified in 

the order that would permit a reasoned 

evaluation of the potential risks posed 

by these chemical substances. Under 

recent TSCA section 5(e) consent orders, 

each PMN submitter is required to 

submit each study at least 14 weeks 

(earlier TSCA section 5(e) consent 

orders required submissions at least 12 

weeks) before reaching the specified 

production limit. Listings of the tests 

specified in the TSCA section 5(e) 

consent orders are included in Unit IV. 

The SNURs contain the same 

production volume limits as the TSCA 

section 5(e) consent orders. Exceeding 

these production limits is defined as a 

significant new use. Persons who intend 


rmajette on DSKBCKNHB2PROD with RULES
48646 Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 

to exceed the production limit must 

notify the Agency by submitting a 

SNUN at least 90 days in advance of 

commencement of non-exempt 

commercial manufacture or processing. 

The recommended tests specified in 

Unit IV. may not be the only means of 

addressing the potential risks of the 

chemical substance. However, 

submitting a SNUN without any test 

data may increase the likelihood that 

EPA will take action under TSCA 

section 5(e), particularly if satisfactory 

test results have not been obtained from 

a prior PMN or SNUN submitter. EPA 

recommends that potential SNUN 

submitters contact EPA early enough so 

that they will be able to conduct the 

appropriate tests. 

SNUN submitters should be aware 

that EPA will be better able to evaluate 

SNUNs which provide detailed 

information on the following: 

• Human exposure and 

environmental release that may result 

from the significant new use of the 

chemical substances. 

• Potential benefits of the chemical 

substances. 

• Information on risks posed by the 

chemical substances compared to risks 

posed by potential substitutes. 

IX. Procedural Determinations 

By this rule, EPA is establishing 

certain significant new uses which have 

been claimed as CBI subject to Agency 

confidentiality regulations at 40 CFR 

part 2 and 40 CFR part 720, subpart E. 

Absent a final determination or other 

disposition of the confidentiality claim 

under 40 CFR part 2 procedures, EPA is 

required to keep this information 

confidential. EPA promulgated a 

procedure to deal with the situation 

where a specific significant new use is 

CBI, at § 721.1725(b)(1). 

Under these procedures a 

manufacturer or processor may request 

EPA to determine whether a proposed 

use would be a significant new use 

under the rule. The manufacturer or 

processor must show that it has a bona 

fide intent to manufacture or process the 

chemical substance and must identify 

the specific use for which it intends to 

manufacture or process the chemical 

substance. If EPA concludes that the 

person has shown a bona fide intent to 

manufacture or process the chemical 

substance, EPA will tell the person 

whether the use identified in the bona 

fide submission would be a significant 

new use under the rule. Since most of 

the chemical identities of the chemical 

substances subject to these SNURs are 

also CBI, manufacturers and processors 

can combine the bona fide submission 

under the procedure in § 721.1725(b)(1) 

with that under § 721.11 into a single 

step. 

If EPA determines that the use 

identified in the bona fide submission 

would not be a significant new use, i.e., 

the use does not meet the criteria 

specified in the rule for a significant 

new use, that person can manufacture or 

process the chemical substance so long 

as the significant new use trigger is not 

met. In the case of a production volume 

trigger, this means that the aggregate 

annual production volume does not 

exceed that identified in the bona fide 

submission to EPA. Because of 

confidentiality concerns, EPA does not 

typically disclose the actual production 

volume that constitutes the use trigger. 

Thus, if the person later intends to 

exceed that volume, a new bona fide 

submission would be necessary to 

determine whether that higher volume 

would be a significant new use. 

X. SNUN Submissions 

According to § 721.1(c), persons 

submitting a SNUN must comply with 

the same notification requirements and 

EPA regulatory procedures as persons 

submitting a PMN, including 

submission of test data on health and 

environmental effects as described in 

§ 720.50. SNUNs must be submitted on 

EPA Form No. 7710–25, generated using 

e-PMN software, and submitted to the 

Agency in accordance with the 

procedures set forth in §§ 720.40 and 

721.25. E–PMN software is available 

electronically at https://www.epa.gov/ 

reviewing-new-chemicals-under-toxicsubstances-control-act-tsca. 

XI. Economic Analysis 

EPA has evaluated the potential costs 

of establishing SNUN requirements for 

potential manufacturers and processors 

of the chemical substances subject to 

this rule. EPA’s complete economic 

analysis is available in the docket under 

docket ID number EPA–HQ–OPPT– 

2017–0166. 

XII. Statutory and Executive Order 

Reviews 

A. Executive Order 12866 

This action establishes SNURs for 

several new chemical substances that 

were the subject of PMNs, or TSCA 

section 5(e) consent orders. The Office 

of Management and Budget (OMB) has 

exempted these types of actions from 

review under Executive Order 12866, 

entitled ‘‘Regulatory Planning and 

Review’’ (58 FR 51735, October 4, 1993). 

B. Paperwork Reduction Act (PRA) 

According to PRA (44 U.S.C. 3501 et 

seq.), an agency may not conduct or 

sponsor, and a person is not required to 

respond to a collection of information 

that requires OMB approval under PRA, 

unless it has been approved by OMB 

and displays a currently valid OMB 

control number. The OMB control 

numbers for EPA’s regulations in title 40 

of the CFR, after appearing in the 

Federal Register, are listed in 40 CFR 

part 9, and included on the related 

collection instrument or form, if 

applicable. EPA is amending the table in 

40 CFR part 9 to list the OMB approval 

number for the information collection 

requirements contained in this action. 

This listing of the OMB control numbers 

and their subsequent codification in the 

CFR satisfies the display requirements 

of PRA and OMB’s implementing 

regulations at 5 CFR part 1320. This 

Information Collection Request (ICR) 

was previously subject to public notice 

and comment prior to OMB approval, 

and given the technical nature of the 

table, EPA finds that further notice and 

comment to amend it is unnecessary. As 

a result, EPA finds that there is ‘‘good 

cause’’ under section 553(b)(3)(B) of the 

Administrative Procedure Act (5 U.S.C. 

553(b)(3)(B)) to amend this table 

without further notice and comment. 

The information collection 

requirements related to this action have 

already been approved by OMB 

pursuant to PRA under OMB control 

number 2070–0012 (EPA ICR No. 574). 

This action does not impose any burden 

requiring additional OMB approval. If 

an entity were to submit a SNUN to the 

Agency, the annual burden is estimated 

to average between 30 and 170 hours 

per response. This burden estimate 

includes the time needed to review 

instructions, search existing data 

sources, gather and maintain the data 

needed, and complete, review, and 

submit the required SNUN. 

Send any comments about the 

accuracy of the burden estimate, and 

any suggested methods for minimizing 

respondent burden, including through 

the use of automated collection 

techniques, to the Director, Collection 

Strategies Division, Office of 

Environmental Information (2822T), 

Environmental Protection Agency, 1200 

Pennsylvania Ave. NW., Washington, 

DC 20460–0001. Please remember to 

include the OMB control number in any 

correspondence, but do not submit any 

completed forms to this address. 

C. Regulatory Flexibility Act (RFA) 

On February 18, 2012, EPA certified 

pursuant to RFA section 605(b) (5 U.S.C. 

605(b)), that promulgation of a SNUR 

does not have a significant economic 

impact on a substantial number of small 

entities where the following are true: 


rmajette on DSKBCKNHB2PROD with RULES
Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 48647 

1. A significant number of SNUNs 

would not be submitted by small 

entities in response to the SNUR. 

2. The SNUR submitted by any small 

entity would not cost significantly more 

than $8,300. 

A copy of that certification is 

available in the docket for this action. 

This action is within the scope of the 

February 18, 2012 certification. Based 

on the Economic Analysis discussed in 

Unit XI. and EPA’s experience 

promulgating SNURs (discussed in the 

certification), EPA believes that the 

following are true: 

• A significant number of SNUNs 

would not be submitted by small 

entities in response to the SNUR. 

• Submission of the SNUN would not 

cost any small entity significantly more 

than $8,300. 

Therefore, the promulgation of the 

SNUR would not have a significant 

economic impact on a substantial 

number of small entities. 

D. Unfunded Mandates Reform Act 

(UMRA) 

Based on EPA’s experience with 

proposing and finalizing SNURs, State, 

local, and Tribal governments have not 

been impacted by these rulemakings, 

and EPA does not have any reasons to 

believe that any State, local, or Tribal 

government will be impacted by this 

action. As such, EPA has determined 

that this action does not impose any 

enforceable duty, contain any unfunded 

mandate, or otherwise have any effect 

on small governments subject to the 

requirements of UMRA sections 202, 

203, 204, or 205 (2 U.S.C. 1502, 1503, 

1504, or 1505 et seq.). 

E. Executive Order 13132 

This action will not have a substantial 

direct effect on States, on the 

relationship between the national 

government and the States, or on the 

distribution of power and 

responsibilities among the various 

levels of government, as specified in 

Executive Order 13132, entitled 

‘‘Federalism’’ (64 FR 43255, August 10, 

1999). 

F. Executive Order 13175 

This action does not have Tribal 

implications because it is not expected 

to have substantial direct effects on 

Indian Tribes. This action does not 

significantly nor uniquely affect the 

communities of Indian Tribal 

governments, nor does it involve or 

impose any requirements that affect 

Indian Tribes. Accordingly, the 

requirements of Executive Order 13175, 

entitled ‘‘Consultation and Coordination 

with Indian Tribal Governments’’ (65 FR 

67249, November 9, 2000), do not apply 

to this action. 

G. Executive Order 13045 

This action is not subject to Executive 

Order 13045, entitled ‘‘Protection of 

Children from Environmental Health 

Risks and Safety Risks’’ (62 FR 19885, 

April 23, 1997), because this is not an 

economically significant regulatory 

action as defined by Executive Order 

12866, and this action does not address 

environmental health or safety risks 

disproportionately affecting children. 

H. Executive Order 13211 

This action is not subject to Executive 

Order 13211, entitled ‘‘Actions 

Concerning Regulations That 

Significantly Affect Energy Supply, 

Distribution, or Use’’ (66 FR 28355, May 

22, 2001), because this action is not 

expected to affect energy supply, 

distribution, or use and because this 

action is not a significant regulatory 

action under Executive Order 12866. 

I. National Technology Transfer and 

Advancement Act (NTTAA) 

In addition, since this action does not 

involve any technical standards, 

NTTAA section 12(d) (15 U.S.C. 272 

note), does not apply to this action. 

J. Executive Order 12898 

This action does not entail special 

considerations of environmental justice 

related issues as delineated by 

Executive Order 12898, entitled 

‘‘Federal Actions to Address 

Environmental Justice in Minority 

Populations and Low-Income 

Populations’’ (59 FR 7629, February 16, 

1994). 

XIII. Congressional Review Act 

Pursuant to the Congressional Review 

Act (5 U.S.C. 801 et seq.), EPA will 

submit a report containing this rule and 

other required information to the U.S. 

Senate, the U.S. House of 

Representatives, and the Comptroller 

General of the United States prior to 

publication of the rule in the Federal 

Register. This action is not a ‘‘major 

rule’’ as defined by 5 U.S.C. 804(2). 

List of Subjects 

40 CFR Part 9 

Environmental protection, Reporting 

and recordkeeping requirements. 

40 CFR Part 721 

Environmental protection, Chemicals, 

Hazardous substances, Reporting and 

recordkeeping requirements. 

Dated: July 7, 2017. 

Maria J. Doa, 

Director, Chemical Control Division, Office 

of Pollution Prevention and Toxics. 

Therefore, 40 CFR parts 9 and 721 are 

amended as follows: 

PART 9—[AMENDED] 

■ 1. The authority citation for part 9 

continues to read as follows: 

Authority: 7 U.S.C. 135 et seq., 136–136y; 

15 U.S.C. 2001, 2003, 2005, 2006, 2601–2671; 

21 U.S.C. 331j, 346a, 348; 31 U.S.C. 9701; 33 

U.S.C. 1251 et seq., 1311, 1313d, 1314, 1318, 

1321, 1326, 1330, 1342, 1344, 1345 (d) and 

(e), 1361; E.O. 11735, 38 FR 21243, 3 CFR, 

1971–1975 Comp. p. 973; 42 U.S.C. 241, 

242b, 243, 246, 300f, 300g, 300g–1, 300g–2, 

300g–3, 300g–4, 300g–5, 300g–6, 300j–1, 

300j–2, 300j–3, 300j–4, 300j–9, 1857 et seq., 

6901–6992k, 7401–7671q, 7542, 9601–9657, 

11023, 11048. 

■ 2. In § 9.1, add the following sections 

in numerical order under the 

undesignated center heading 

‘‘Significant New Uses of Chemical 

Substances’’ to read as follows: 

§ 9.1 OMB approvals under the Paperwork 

Reduction Act. 

* * * * * 

40 CFR citation OMB 

control No. 

*****

Significant New Uses of Chemical 

Substances 

*****

721.10996 ............................. 2070–0012 

721.10997 ............................. 2070–0012 

721.10998 ............................. 2070–0012 

721.10999 ............................. 2070–0012 

721.11000 ............................. 2070–0012 

721.11001 ............................. 2070–0012 

721.11002 ............................. 2070–0012 

721.11003 ............................. 2070–0012 

721.11004 ............................. 2070–0012 

721.11005 ............................. 2070–0012 

721.11006 ............................. 2070–0012 

721.11007 ............................. 2070–0012 

721.11008 ............................. 2070–0012 

721.11009 ............................. 2070–0012 

721.11010 ............................. 2070–0012 

721.11011 ............................. 2070–0012 

721.11012 ............................. 2070–0012 

721.11013 ............................. 2070–0012 

721.11014 ............................. 2070–0012 

721.11015 ............................. 2070–0012 

721.11016 ............................. 2070–0012 

721.11017 ............................. 2070–0012 

721.11018 ............................. 2070–0012 

721.11019 ............................. 2070–0012 

*****

* * * * * 


rmajette on DSKBCKNHB2PROD with RULES
48648 Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 

PART 721—[AMENDED] 

■ 3. The authority citation for part 721 

continues to read as follows: 

Authority: 15 U.S.C. 2604, 2607, and 

2625(c). 

■ 4. Add § 721.10996 to subpart E to 

read as follows: 

§ 721.10996 1,2,4-Benzenetricarboxylic 

acid, mixed decyl and octyl triesters. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

1,2,4-benzenetricarboxylic acid, mixed 

decyl and octyl triesters (PMN P–15– 

310) is subject to reporting under this 

section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(1) and (3) and (b) 

(concentration set at 1.0 percent). 

(ii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(p) (2,440,000 

kilograms), (s) (150,000 kilograms). It is 

a significant new use to use the PMN 

substance other than as a lubricant in 

chain oils for conveyor belts. 

(iii) Hazard communication program. 

A significant new use of the substance 

is any manner or method of 

manufacture or processing associated 

with any use of the substance without 

providing risk notification as follows: 

(A) If as a result of the test data 

required under the TSCA section 5(e) 

consent order for the substance, the 

employer becomes aware that the 

substance may present a risk of injury 

to human health or the environment, the 

employer must incorporate this new 

information, and any information on 

methods for protecting against such risk, 

into a MSDS as described in § 721.72(c) 

within 90 days from the time the 

employer becomes aware of the new 

information. If the substance is not 

being manufactured, processed, or used 

in the employer’s workplace, the 

employer must add the new information 

to a MSDS before the substance is 

reintroduced into the workplace. 

(B) The employer must ensure that 

persons who will receive the PMN 

substance from the employer, or who 

have received the PMN substance from 

the employer within 5 years from the 

date the employer becomes aware of the 

new information described in paragraph 

(a)(2)(iii)(A) of this section, are provided 

an MSDS containing the information 

required under paragraph (a)(2)(iii)(A) 

of this section within 90 days from the 

time the employer becomes aware of the 

new information. 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (f) and (i) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 5. Add § 721.10997 to subpart E to 

read as follows: 

§ 721.10997 Multiwalled carbon nanotubes 

(generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substances identified 

generically as multiwalled carbon 

nanotubes (PMN P–15–487/488/489/ 

490/491) are subject to reporting under 

this section for the significant new uses 

described in paragraph (a)(2) of this 

section. The requirements of this section 

do not apply when the PMN substances 

have been incorporated into a polymer 

matrix that has been reacted (cured) or 

embedded in a permanent solid polymer 

form that is not intended to undergo 

further processing except mechanical 

processing. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(1), (a)(2)(i) and (ii), (a)(3), 

(4), and (6) (particulate), and (c). When 

determining which persons are 

reasonably likely to be exposed as 

required for § 721.63(a)(1) and (4), 

engineering control measures (e.g., 

enclosure or confinement of the 

operation, general and local ventilation) 

or administrative control measures (e.g., 

workplace policies and procedures) 

shall be considered and implemented to 

prevent exposure, where feasible. The 

following National Institute for 

Occupational Safety and Health 

(NIOSH)-certified respirators with an 

APF of at least 50 meet the requirements 

of § 721.63(a)(4): 

(A) A NIOSH-certified air-purifying, 

tight-fitting full-face respirator equipped 

with N–100, P–100, or R–100 cartridges. 

(B) Any NIOSH-certified powered airpurifying respirator equipped with a 

tight-fitting full facepiece and equipped 

with HEPA filters. 

(C) Any NIOSH-certified negative 

pressure (demand) supplied-air 

respirator equipped with a full 

facepiece. 

(ii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(k) (additives for 

electro-static discharge in electronic 

devices, electronics, and materials; 

additives for weight reduction in 

materials; additives to improve 

mechanical properties or electrical 

conductivities; heat-generating elements 

in heating devices and materials; 

additives for heat transfer and thermal 

emissions in electronic devices and 

materials; semi-conductor, conductive, 

or resistive elements in electronic 

circuity and devices; additives to 

improve conductivity in electronic 

circuitry, energy storage systems, and 

devices; electron emitters for lighting 

and x-ray sources; additive for 

electromagnetic interface shielding in 

electronic devices; additives for 

electrodes in electronic materials and 

electronic devices; catalyst support in 

chemical manufacturing; coating 

additives to improve corrosion 

resistance of conductive properties; 

additives for fibers in structural and 

electrical applications; additives for 

fibers in fabrics and textiles; filter 

additives to remove nanoscale materials; 

semi-conducting compounding 

additives for high-voltage cable; and 

additives for super-hydrophobicity). A 

significant new use is any use involving 

an application method that generates a 

dust, mist or aerosol. 

(iii) Disposal. Requirements as 

specified in § 721.85(a)(1) and (2), (b)(1) 

and (2), and (c)(1) and (2). 

(iv) Release to water. Requirements as 

specified in § 721.90(a)(1), (b)(1), and 

(c)(1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (e) and (i) through 

(k) are applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 6. Add § 721.10998 to subpart E to 

read as follows: 

§ 721.10998 Propanoic acid, iron (2+) salt 

(2:1). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

propanoic acid, iron (2+) salt (2:1) (CAS 

#1952336–63–8) (PMN P–16–165) is 

subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(4) and (5) (particulate) and 

(b) (concentration set at 1.0 percent). 


rmajette on DSKBCKNHB2PROD with RULES
Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 48649 

When determining which persons are 

reasonably likely to be exposed as 

required for § 721.63(a)(4), engineering 

control measures (e.g., enclosure or 

confinement of the operation, general 

and local ventilation) or administrative 

control measures (e.g., workplace 

policies and procedures) shall be 

considered and implemented to prevent 

exposure, where feasible. The following 

National Institute for Occupational 

Safety and Health (NIOSH)-certified 

respirators with an APF of at least 10 

meet the requirements of § 721.63(a)(4): 

(A) NIOSH-certified respirator with an 

N–100, P–100, or R–100 cartridge. 

(B) NIOSH-certified power air 

purifying respirator with a hood or 

helmet and with appropriate gas/vapor 

(acid gas, organic vapor, or substance 

specific) cartridges in combination with 

HEPA filters. 

(C) NIOSH-certified continuous flow 

supplied-air respirator equipped with a 

loose fitting facepiece, hood, or helmet. 

(ii) Hazard communication. 

Requirements as specified in § 721.72(a) 

through (e) (concentration set at 1.0 

percent), (f), (g)(1)(iv) and (ix), (g)(2)(ii), 

(iii), and (iv), and (g)(5). Alternative 

hazard and warning statements that 

meet the criteria of the Globally 

Harmonized System (GHS) and OSHA 

Hazard Communication Standard may 

be used. 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(l), (p) (270,000 

kilograms), (s) (5,000 kilograms). It is a 

significant new use to use the substance 

in formulations where the concentration 

is greater than 1 percent. 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (d) and (f) through 

(i) are applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 7. Add § 721.10999 to subpart E to 

read as follows: 

§ 721.10999 1-Butanaminium, N,N,Ntributyl-, carbonic acid (1:1). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

1-butanaminium, N,N,N-tributyl-, 

carbonic acid (1:1) (PMN P–16–255; 

CAS No. 17351–62–1) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(1) and (3) and (b) 

(concentration set at 1.0 percent). 

(ii) Hazard communication. 

Requirements as specified in § 721.72(a) 

through (e) (concentration set at 1.0 

percent), (f), (g)(1)(i) and (ii), (g)(2)(i), 

(ii), (iii), and (v), (g)(3)(i) and (ii), and 

(g)(5) and Notice to users: Minimize 

release to water. Alternative hazard and 

warning statements that meet the 

criteria of the Globally Harmonized 

System (GHS) and OSHA Hazard 

Communication Standard may be used. 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(p) (64,000 

kilograms aggregate of P–16–255, P–16– 

256, P–16–257, P–16–258, and P–16– 

259). It is a significant new use to 

manufacture, process, or use the 

substance other than as a blocked 

catalyst for paints and coatings. It is a 

significant new use to spray apply the 

PMN substance where the concentration 

of any combination of P–16–255, P–16– 

256, P–16–257, P–16–258, and P–16– 

259 in the final paint/coating 

formulation exceeds 1.5% by weight. 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (i) are applicable to 

manufacturers and processors of this 

substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 8. Add § 721.11000 to subpart E to 

read as follows: 

§ 721.11000 1-Butanaminium, N,N,Ntributyl-, methyl carbonate (1:1). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

1-Butanaminium, N,N,N-tributyl-, 

methyl carbonate (1:1) (PMN P–16–256; 

CAS No. 56294–05–2) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(1) and (3) and (b) 

(concentration set at 1.0 percent). 

(ii) Hazard communication. 

Requirements as specified in § 721.72(a) 

through (e) (concentration set at 1.0 

percent), (f), (g)(1)(i) and (ii), (g)(2)(i), 

(ii), (iii), and (v), (g)(3)(i) and (ii), and 

(g)(5) and Notice to users: Minimize 

release to water. Alternative hazard and 

warning statements that meet the 

criteria of the Globally Harmonized 

System (GHS) and OSHA Hazard 

Communication Standard may be used. 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(p) (64,000 

kilograms aggregate of P–16–255, P–16– 

256, P–16–257, P–16–258, and P–16– 

259). It is a significant new use to 

manufacture, process, or use the 

substance other than as a blocked 

catalyst for paints and coatings. It is a 

significant new use to spray apply the 

PMN substance where the concentration 

of any combination of P–16–255, P–16– 

256, P–16–257, P–16–258, and P–16– 

259 in the final paint/coating 

formulation exceeds 1.5% by weight. 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (i) are applicable to 

manufacturers and processors of this 

substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 9. Add § 721.11001 to subpart E to 

read as follows: 

§ 721.11001 1-Butanaminium, N,N,Ntributyl-, ethyl carbonate (1:1). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

1-butanaminium, N,N,N-tributyl-, ethyl 

carbonate (1:1) (PMN P–16–257; CAS 

No. 478796–04–2) is subject to reporting 

under this section for the significant 

new uses described in paragraph (a)(2) 

of this section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(1) and (3) and (b) 

(concentration set at 1.0 percent). 

(ii) Hazard communication. 

Requirements as specified in § 721.72(a) 

through (e) (concentration set at 1.0 

percent), (f), (g)(1)(i) and (ii), (g)(2)(i), 

(ii), (iii), and (v), (g)(3)(i) and (ii), and 

(g)(5) and Notice to users: Minimize 

release to water. Alternative hazard and 

warning statements that meet the 

criteria of the Globally Harmonized 

System (GHS) and OSHA Hazard 

Communication Standard may be used. 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(p)(64,000 

kilograms aggregate of P–16–255, P–16– 

256, P–16–257, P–16–258, and P–16– 

259). It is a significant new use to 


rmajette on DSKBCKNHB2PROD with RULES
48650 Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 

manufacture, process, or use the 

substance other than as a blocked 

catalyst for paints and coatings. It is a 

significant new use to spray apply the 

PMN substance where the concentration 

of any combination of P–16–255, P–16– 

256, P–16–257, P–16–258, and P–16– 

259 in the final paint/coating 

formulation exceeds 1.5% by weight. 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (i) are applicable to 

manufacturers and processors of this 

substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 10. Add § 721.11002 to subpart E to 

read as follows: 

§ 721.11002 1-Butanaminium, N,N,Ntributyl-, propyl carbonate (1:1). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

1-butanaminium, N,N,N-tributyl-, 

propyl carbonate (1:1) (PMN P–16–258: 

CAS No. 1338579–13–7) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(1) and (3) and (b) 

(concentration set at 1.0 percent). 

(ii) Hazard communication. 

Requirements as specified in § 721.72(a) 

through (e) (concentration set at 1.0 

percent), (f), (g)(1)(i) and (ii), (g)(2)(i), 

(ii), (iii), and (v), (g)(3)(i) and (ii), and 

(g)(5) and Notice to users: Minimize 

release to water. Alternative hazard and 

warning statements that meet the 

criteria of the Globally Harmonized 

System (GHS) and OSHA Hazard 

Communication Standard may be used. 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(p) (64,000 

kilograms aggregate of P–16–255, P–16– 

256, P–16–257, P–16–258, and P–16– 

259). It is a significant new use to 

manufacture, process, or use the 

substance other than as a blocked 

catalyst for paints and coatings. It is a 

significant new use to spray apply the 

PMN substance where the concentration 

of any combination of P–16–255, P–16– 

256, P–16–257, P–16–258, and P–16– 

259 in the final paint/coating 

formulation exceeds 1.5% by weight. 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (i) are applicable to 

manufacturers and processors of this 

substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 11. Add § 721.11003 to subpart E to 

read as follows: 

§ 721.11003 1-Butanaminium, N,N,Ntributyl-, and 1-methylethyl carbonate. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

1-butanaminium, N,N,N-tributyl-, and 1- 

methylethyl carbonate (PMN P–16–259; 

CAS No. 1803407–49–9) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(1) and (3) and (b) 

(concentration set at 1.0 percent). 

(ii) Hazard communication. 

Requirements as specified in § 721.72(a) 

through (e) (concentration set at 1.0 

percent), (f), (g)(1)(i) and (ii), (g)(2)(i), 

(ii), (iii), and (v), (g)(3)(i) and (ii), (g)(4) 

(Notice to users: Minimize release to 

water), and (g)(5). Alternative hazard 

and warning statements that meet the 

criteria of the Globally Harmonized 

System (GHS) and OSHA Hazard 

Communication Standard may be used. 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(p) (64,000 

kilograms aggregate of P–16–255, P–16– 

256, P–16–257, P–16–258, and P–16– 

259). It is a significant new use to 

manufacture, process, or use the 

substance other than as a blocked 

catalyst for paints and coatings. It is a 

significant new use to spray apply the 

PMN substance where the concentration 

of any combination of P–16–255, P–16– 

256, P–16–257, P–16–258, and P–16– 

259 in the final paint/coating 

formulation exceeds 1.5% by weight. 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (i) are applicable to 

manufacturers and processors of this 

substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 12. Add § 721.11004 to subpart E to 

read as follows: 

§ 721.11004 Anilino substituted bistriazinyl derivative of 4,4′-diaminostilbene2,2′-disulfonic acid, mixed amine sodium 

salt (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as anilino substituted bistriazinyl derivative of 4,4′- 

diaminostilbene-2,2′-disulfonic acid, 

mixed amine sodium salt (PMN P–16– 

284) is subject to reporting under this 

section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(f). It is a significant 

new use to import or use the substance 

other than in a solution. It is a 

significant new use to use the substance 

other than as an optical brightener for 

textiles, paper, and paperboard. It is a 

significant new use to use the substance 

for non-industrial use or sell the 

substance for ‘‘consumer use’’ or for 

‘‘commercial uses’’ (as the term is 

defined at § 721.3) when the ‘‘saleable 

goods or service’’ could introduce the 

substance into a ‘‘consumer’’ setting (as 

that term is defined in § 721.3). It is a 

significant new use to use the substance 

for an application method that generates 

a dust, mist, or aerosol unless the 

application method occurs in an 

enclosed process. 

(ii) [Reserved]. 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c) and (i) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 13. Add § 721.11005 to subpart E to 

read as follows: 

§ 721.11005 12-Hydroxystearic acid, 

reaction products with alkylene diamine 

and alkanoic acid (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substances identified 

generically as 12-Hydroxystearic acid, 

reaction products with alkylene diamine 

and alkanoic acid (PMNs P–16–309 and 

P–16–310) are subject to reporting under 

this section for the significant new uses 

described in paragraph (a)(2) of this 

section. 


rmajette on DSKBCKNHB2PROD with RULES
Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 48651 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(f), (q), and (t). It is 

a significant new use to use the PMN 

substance other than as a rheological or 

thixotropic agent used in the production 

of solvent based industrial coatings, 

high solid aromatic paints, adhesives, 

sealants, and other types of paints and 

topcoats. 

(ii) Releases to water. Requirements as 

specified in § 721.90(a)(4), (b)(4), and 

(c)(4) (N=2). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), (i), and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to paragraph 

(a)(2)(ii) of this section. 

■ 14. Add § 721.11006 to subpart E to 

read as follows: 

§ 721.11006 Alkyldiene, polymer, hydroxy 

terminated alkoxysilylalkylcarbamate. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as alkyldiene, polymer, 

hydroxy terminated 

alkoxysilylalkylcarbamate (PMN P–16– 

315) is subject to reporting under this 

section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(f). It is a significant 

new use to process the substance in a 

manner that results in inhalation 

exposure. It is a significant new use to 

use the PMN substance other than as an 

additive to improve the compatibility 

and dispersibility of inorganic filler in 

industrial rubber formulations. 

(ii) [Reserved]. 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c) and (i) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 15. Add § 721.11007 to subpart E to 

read as follows: 

§ 721.11007 Alkylaldehyde, reaction 

products with substituted carbomonocyclesubstituted heteromonocycle-alkylene 

glycol 

bis[[[[substituted(oxoneoalkyl)oxy]alkyl] 

amino]alkyl] ether polymer and alkyl 

substituted alkanediamine, acetate salts 

(generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as alkylaldehyde, reaction 

products with substituted 

carbomonocycle-substituted 

heteromonocycle-alkylene glycol 

bis[[[[substituted(oxoneoalkyl)oxy]alkyl] 

amino]alkyl] ether polymer and alkyl 

substituted alkanediamine, acetate salts 

(generic) (PMN P–16–323) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Hazard communication. 

Requirements as specified in § 721.72(a) 

through (e) (concentration set at 0.1 

percent), (f), (g)(1) (respiratory tract 

irritation), (g)(1)(i) and (vii), (g)(2)(i), (ii), 

and (iii), (g)(3)(i) and (ii), and (g)(5). 

Alternative hazard and warning 

statements that meet the criteria of the 

Globally Harmonized System (GHS) and 

OSHA Hazard Communication Standard 

may be used. 

(ii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(j). It is a significant 

new use to manufacture the PMN 

substance to contain a residual of 

formaldehyde greater than 0.1 weight 

percent. It is a significant new use to 

manufacture the substance in a manner 

that results in inhalation exposure. 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), (f), (g), and (h) 

are applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to paragraph 

(a)(2)(ii) of this section. 

■ 16. Add § 721.11008 to subpart E to 

read as follows: 

§ 721.11008 Hydroxy functional 

triglyceride polymer with glycerol monoester and 1,1′-methylenebis[4- 

isocyanatobenzene] (generic). 

(a) Chemical substances and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as hydroxy functional 

triglyceride polymer with glycerol 

mono-ester and 1,1′-methylenebis[4- 

isocyanatobenzene] (PMN P–16–330) is 

subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(1), (a)(2)(i), (iii), and (iv), 

(a)(3), and (b) (concentration set at 0.1 

percent) 

(ii) Hazard communication. 

Requirements as specified in § 721.72(a) 

through (e) (concentration set at 1.0 

percent), (f), (g)(1)(i) and (ii), (g)(2)(i), 

(ii), (iii), and (v), and (g)(5). Alternative 

hazard and warning statements that 

meet the criteria of the Globally 

Harmonized System (GHS) and OSHA 

Hazard Communication Standard may 

be used. 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80. It is a significant 

new use to manufacture the PMN 

substance to contain a residual of 

isocyanate greater than 0.1 weight 

percent. It is a significant new use to 

sell the substance for ‘‘consumer use’’ or 

for ‘‘commercial uses’’ (as the term is 

defined at § 721.3) when the ‘‘saleable 

goods or service’’ could introduce the 

substance into a ‘‘consumer’’ setting (as 

that term is defined in § 721.3). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (i) are applicable to 

manufacturers and processors of this 

substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 17. Add § 721.11009 to subpart E to 

read as follows: 

§ 721.11009 Hydroxy functional 

triglyceride polymer with glycerol monoester and 1,1′- 

methylenebis[isocyanatobenzene] 

(generic). 

(a) Chemical substances and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as hydroxy functional 

triglyceride polymer with glycerol 


rmajette on DSKBCKNHB2PROD with RULES
48652 Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 

mono-ester and 1,1′- 

methylenebis[isocyanatobenzene] (PMN 

P–16–331) is subject to reporting under 

this section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(1), (a)(2)(i), (iii), and (iv), 

(a)(3), and (b) (concentration set at 0.1 

percent). 

(ii) Hazard communication. 

Requirements as specified in § 721.72(a) 

through (e) (concentration set at 1.0 

percent), (f), (g)(1)(i) and (ii), (g)(2)(i), 

(ii), (iii), and (v), and (g)(5). Alternative 

hazard and warning statements that 

meet the criteria of the Globally 

Harmonized System (GHS) and OSHA 

Hazard Communication Standard may 

be used. 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80. It is a significant 

new use to manufacture the PMN 

substance to contain a residual of 

isocyanate greater than 0.1 weight 

percent. It is a significant new use to 

sell the substance for ‘‘consumer use’’ or 

for ‘‘commercial uses’’ (as the term is 

defined at § 721.3) when the ‘‘saleable 

goods or service’’ could introduce the 

substance into a ‘‘consumer’’ setting (as 

that term is defined in § 721.3). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (i) are applicable to 

manufacturers and processors of this 

substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 18. Add § 721.11010 to subpart E to 

read as follows: 

§ 721.11010 Poly(oxy-1,2- 

ethanediyl),.alpha.-(1-oxodocosyl)-.omega.- 

[(1-oxodocosyl)oxy]- 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as poly(oxy-1,2- 

ethanediyl),.alpha.-(1-oxodocosyl)- 

.omega.-[(1-oxodocosyl)oxy]- (PMN P– 

16–360; CAS No. 36493–27–3) is subject 

to reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80. It is a significant 

new use to manufacture the PMN 

substance such that more than 33% 

contains 10 or more repeating ethylene 

oxide units. 

(ii) [Reserved]. 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c) and (i) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 19. Add § 721.11011 to subpart E to 

read as follows: 

§ 721.11011 Pulp, cellulose, reaction 

products with lignin. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as pulp, cellulose, reaction 

products with lignin (PMN P–16–361; 

CAS No. 167062–70–6) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. The 

requirements of this section do not 

apply to quantities of the PMN 

substance after they have been 

incorporated into a polymer matrix. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(y)(1). It is a 

significant new use to manufacture, 

process, or use the PMN substance other 

than in a liquid or gel formulation, 

unless the solid particle form has a 

particle size distribution where less 

than 0.5% of the particles are less than 

10 microns. It is a significant new use 

to manufacture the solid particle form 

more than six months without 

measuring the particle size distribution 

to characterize the particle size 

distribution of fractions less than 10 

microns of the dry particle PMN 

substance and sending the results of the 

measurement to EPA. 

(ii) [Reserved]. 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c) and (i) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 20. Add § 721.11012 to subpart E to 

read as follows: 

§ 721.11012 Alkyl carbonate, polymer with, 

substituted alkanes and substituted 

heteromonocycle, substituted alkyl 

acrylate-blocked (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as alkyl carbonate, polymer 

with, substituted alkanes and 

substituted heteromonocycle, 

substituted alkyl acrylate-blocked 

(generic) (PMN P–16–365) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(1) and (3) and (b) 

(concentration set at 0.1 percent). 

(ii) Hazard communication. 

Requirements as specified in § 721.72(a) 

through (e) (concentration set at 0.1 

percent), (f), (g)(1) (lung effects), (g)(1) 

(sensitization), (g)(1)(vii), (g)(2)(i), (ii), 

(iii), and (v), and (g)(5). 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80. It is a significant 

new use to manufacture the substance to 

contain a residual of isocyanate greater 

than 0.1 weight percent. It is a 

significant new use to sell the substance 

for ‘‘consumer use’’ or for ‘‘commercial 

uses’’ (as the term is defined at § 721.3) 

when the ‘‘saleable goods or service’’ 

could introduce the substance into a 

‘‘consumer’’ setting (as that term is 

defined in § 721.3). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (i) are applicable to 

manufacturers and processors of this 

substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 21. Add § 721.11013 to subpart E to 

read as follows: 

§ 721.11013 Substituted heteromonocycle, 

polymer with substituted alkane and 

ethoxylated alkane, substituted 

heteromonocycle substituted alkyl esterblocked (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as substituted 

heteromonocycle, polymer with 

substituted alkane and ethoxylated 

alkane, substituted heteromonocycle 


rmajette on DSKBCKNHB2PROD with RULES
Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 48653 

substituted alkyl ester-blocked (PMN P– 

16–367) is subject to reporting under 

this section for the significant new uses 

described in paragraph (a)(2) of this 

section. The requirements of this section 

do not apply to quantities of the PMN 

substance after they have been 

completely reacted (cured). 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(1) and (3) and (b) 

(concentration set at 0.1 percent). 

(ii) Hazard communication. 

Requirements as specified in § 721.72(a) 

through (e) (concentration set at 0.1 

percent), (f), (g)(1) (lung effects), (g)(1) 

(sensitization), (g)(1)(vii), (g)(2)(i), (ii), 

(iii), and (v), and (g)(5). 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80. It is a significant 

new use to manufacture the substance to 

contain a residual of isocyanate greater 

than 0.1 weight percent. It is a 

significant new use to sell the substance 

for ‘‘consumer use’’ or for ‘‘commercial 

uses’’ (as the term is defined at § 721.3) 

when the ‘‘saleable goods or service’’ 

could introduce the substance into a 

‘‘consumer’’ setting (as that term is 

defined in § 721.3). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (i) are applicable to 

manufacturers and processors of this 

substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 22. Add § 721.11014 to subpart E to 

read as follows: 

§ 721.11014 Substituted heteromonocycle, 

telomer with substituted carbomonocycles, 

substituted alkyl ester (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as substituted 

heteromonocycle, telomer with 

substituted carbomonocycles, 

substituted alkyl ester (PMN P–16–369) 

is subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. The 

requirements of this section do not 

apply to quantities of the PMN 

substance after they have been 

completely reacted (cured). 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(1), (3), and (4), (a)(6) 

(particulate), (a)(6)(v) and (vi), and (b) 

(concentration set at 0.1 percent). The 

following National Institute for 

Occupational Safety and Health 

(NIOSH)-certified respirators with an 

APF of at least 50 meet the requirements 

of § 721.63(a)(4): 

(A) Any NIOSH-certified air-purifying 

full facepiece respirator equipped with 

N100 (if oil aerosols absent), R–100, or 

P–100 filter(s). 

(B) Any NIOSH-certified powered airpurifying respirator equipped with a 

tight-fitting full facepiece and equipped 

with HEPA filters. 

(C) Any NIOSH-certified negative 

pressure (demand) supplied-air 

respirator equipped with a full 

facepiece. 

(D) Any NIOSH-certified continuous 

flow supplied-air respirator equipped 

with a tight-fitting full facepiece (half or 

full facepiece). 

(E) Any NIOSH-certified negative 

pressure (demand) self-contained 

breathing apparatus (SCBA) equipped 

with a hood or helmet or a full 

facepiece. 

(ii) Hazard communication. 

Requirements as specified in § 721.72(a) 

through (e) (concentration set at 0.1 

percent), (f), (g)(1) (lung effects), (g)(1) 

(sensitization), (g)(1)(vii), (g)(2)(i), (ii), 

(iii), and (v), and (g)(5). 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(q). It is a 

significant new use to manufacture the 

substance to contain residuals greater 

than 0.1 weight percent of chemicals 

described in the 5(e) consent order. It is 

a significant new use to sell the 

substance for ‘‘consumer use’’ or for 

‘‘commercial uses’’ (as the term is 

defined at § 721.3) when the ‘‘saleable 

goods or service’’ could introduce the 

substance into a ‘‘consumer’’ setting (as 

that term is defined in § 721.3). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (i) are applicable to 

manufacturers and processors of this 

substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to paragraph 

(a)(2)(ii) of this section. 

■ 23. Add § 721.11015 to subpart E to 

read as follows: 

§ 721.11015 Aliphatic polycarboxylic acid, 

polymer with alicyclic polyhydric alcohol 

and polyoxyalkylene (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as aliphatic polycarboxylic 

acid, polymer with alicyclic polyhydric 

alcohol and polyoxyalkylene (PMN P– 

16–387) is subject to reporting under 

this section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Hazard communication. 

Requirements as specified in § 721.72(a) 

through (e) (concentration set at 1.0 

percent), (f), (g)(1)(ii), (g)(2)(ii), (g)(3)(i) 

and (ii), and (g)(5). Alternative hazard 

and warning statements that meet the 

criteria of the Globally Harmonized 

System (GHS) and OSHA Hazard 

Communication Standard may be used. 

(ii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(y)(1) and (2). It is 

a significant new use to manufacture the 

substance with a molecular weight less 

than 18,000 daltons. 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c) and (f) through 

(i) are applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 24. Add § 721.11016 to subpart E to 

read as follows: 

§ 721.11016 Di-ammonium di-carboxylate 

(generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as di-ammonium dicarboxylate (PMN P–16–398) is subject 

to reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(1), (a)(2)(i), (iii), and (iv), 

(a)(3), and (b) (concentration set at 1.0 

percent). 

(ii) Hazard communication. 

Requirements as specified in § 721.72(a) 

through (e) (concentration set at 1.0 

percent), (f), (g)(1) (skin sensitization), 

(g)(1)(i), (g)(2)(i) and (v), and (g)(5). 

Alternative hazard and warning 

statements that meet the criteria of the 

Globally Harmonized System (GHS) and 


rmajette on DSKBCKNHB2PROD with RULES
48654 Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 

OSHA Hazard Communication Standard 

may be used. 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(j) and (q). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (i) are applicable to 

manufacturers and processors of this 

substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to paragraph 

(a)(2)(ii) of this section. 

■ 25. Add § 721.11017 to subpart E to 

read as follows: 

§ 721.11017 Sodium tungsten oxide. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

sodium tungsten oxide (PMN P–16–455) 

is subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. The 

requirements of this section do not 

apply to quantities of the substance that 

have been incorporated into a polymer 

matrix. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(1), (3), (4), and (6) 

(particulate). The following National 

Institute for Occupational Safety and 

Health (NIOSH)-certified respirators 

with an APF of at least 1000 meet the 

requirements of § 721.63(a)(4): 

(A) Any NIOSH-certified powered air 

purifying full facepiece respirator 

equipped with appropriate gas/vapor 

(acid gas, organic vapor, or substance 

specific) cartridges. 

(B) Any NIOSH-certified continuous 

flow supplied-air respirator equipped 

with a full facepiece. 

(C) Any NIOSH-certified pressuredemand or other positive pressure mode 

supplied-air respirator equipped with a 

full facepiece. 

(D) Any NIOSH-certified continuous 

flow supplied-air respirator equipped 

with a full facepiece. 

(E) Any NIOSH-certified pressuredemand or other positive pressure mode 

supplied-air respirator equipped with a 

full facepiece. 

(1) As an alternative to the respiratory 

requirements listed here, a manufacturer 

or processor may choose to follow the 

New Chemical Exposure Limit (NCEL) 

provisions listed in the TSCA section 

5(e) consent order for this substance. 

The NCEL is 0.3 mg/m3 as an 8-hour 

time weighted average verified by actual 

monitoring data. 

(2) [Reserved]. 

(ii) Hazard communication. 

Requirements as specified in § 721.72(a) 

through (e) (concentration set at 0.1 

percent), (f), (g)(1) (lung effects), 

(g)(1)(vii), (g)(2)(ii), (iii), and (iv), 

(g)(3)(ii), (g)(4)(i) and (iii), and (g)(5). 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(q). It is a 

significant new use to use the PMN 

substance other than as a component of 

infrared absorption material. It is a 

significant new use for any application 

method that generates a dust, mist, or 

aerosol, unless such application method 

occurs in an enclosed process. 

(iv) Disposal. Requirements as 

specified in § 721.85(a)(1) and (2), (b)(1) 

and (2), and (c)(1) and (2). 

(v) Releases to water. Requirements as 

specified in § 721.90(a)(1), (b)(1), and 

(c)(1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (k) are applicable 

to manufacturers and processors of this 

substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to paragraph 

(a)(2)(ii) of this section. 

■ 26. Add § 721.11018 to subpart E to 

read as follows: 

§ 721.11018 Fatty acids, tall-oil, polymers 

with alkanoic acid, substituted 

carbomonocycle, alkyl peroxide-initiated 

(generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as fatty acids, tall-oil, 

polymers with alkanoic acid, 

substituted carbomonocycle, alkyl 

peroxide-initiated (PMN P–16–503) is 

subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. The 

requirements of this section do not 

apply to quantities of the PMN 

substance that have been completely 

reacted (cured). 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(g). It is a 

significant new use to manufacture the 

substance to have an average molecular 

weight less than 1500 daltons. It is a 

significant new use to manufacture the 

substance to have more than 24% by 

weight of the acid component identified 

in the 5(e) consent order. 

(ii) [Reserved]. 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c) and (i) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to paragraph 

(a)(2)(ii) of this section. 

■ 27. Add § 721.11019 to subpart E to 

read as follows: 

§ 721.11019 Alkyl bisphenol (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as alkyl bisphenol (PMN P– 

16–591) is subject to reporting under 

this section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(1), (a)(2)(i), (ii), and (iv), 

(a)(3) and (4), (a)(6)(v) and (vi), (a)(6) 

(particulate), and (b) (concentration set 

at 1.0 percent). When determining 

which persons are reasonably likely to 

be exposed as required for 

§ 721.63(a)(4), engineering control 

measures (e.g., enclosure or 

confinement of the operation, general 

and local ventilation) or administrative 

control measures (e.g., workplace 

policies and procedures) shall be 

considered and implemented to prevent 

exposure, where feasible. The following 

National Institute for Occupational 

Safety and Health (NIOSH)-certified 

respirators with an APF of at least 10 

meet the requirements of § 721.63(a)(4): 

(A) NIOSH-certified respirator with an 

N–100, P–100, or R–100 cartridge. 

(B) NIOSH-certified power air 

purifying respirator with a hood or 

helmet and with appropriate gas/vapor 

(acid gas, organic vapor, or substance 

specific) cartridges in combination with 

HEPA filters. 


rmajette on DSKBCKNHB2PROD with RULES
Federal Register / Vol. 82, No. 201 / Thursday, October 19, 2017 / Rules and Regulations 48655 

(C) NIOSH-certified continuous flow 

supplied-air respirator equipped with a 

loose fitting facepiece, hood, or helmet. 

(ii) Hazard communication. 

Requirements as specified in § 721.72(a) 

through (e) (concentration set at 0.1 

percent), (f), (g)(1) (dermal 

sensitization), (g)(1) (endocrine 

disruption), (g)(1) (reproductive effects), 

(g)(1)(i), (ii), (iv), and (ix), (g)(2)(i), (ii), 

(iii), (iv), and (v), (g)(3)(i) and (ii), 

(g)(4)(iii), and (g)(5). Alternative hazard 

and warning statements that meet the 

criteria of the Globally Harmonized 

System (GHS) and OSHA Hazard 

Communication Standard may be used. 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(q). It is a 

significant new use to use the PMN 

substance in thermal paper printing 

(iv) Releases to water. Requirements 

as specified in § 721.90(a)(1), (b)(1), and 

(c)(1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph (b). 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (i) and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to paragraph 

(a)(2)(ii) of this section. 

Editorial note: This document was 

received for publication by the Office of the 

Federal Register on October 10, 2017. 

[FR Doc. 2017–22239 Filed 10–18–17; 8:45 am] 

BILLING CODE 6560–50–P 

DEPARTMENT OF TRANSPORTATION 

Pipeline and Hazardous Materials 

Safety Administration 

49 CFR Parts 191 and 192 

[Docket No. PHMSA–2016–0016; Amdt. Nos. 

191–24; 192–122] 

RIN 2137–AF22 

Pipeline Safety: Safety of Underground 

Natural Gas Storage Facilities 

AGENCY: Pipeline and Hazardous 

Materials Safety Administration 

(PHMSA); DOT. 

ACTION: Interim final rule; reopening 

comment period. 

SUMMARY: The Pipeline and Hazardous 

Materials Safety Administration 

(PHMSA) is announcing an additional 

opportunity for the public to comment 

on an interim final rule (IFR) titled: 

‘‘Pipeline Safety: Underground Natural 

Gas Storage Facilities.’’ PHMSA is 

reopening the comment period in 

response to a petition for 

reconsideration filed jointly by the 

American Gas Association, American 

Petroleum Institute, and the American 

Public Gas Association. By reopening 

the comment period, PHMSA is 

providing all interested parties with the 

opportunity to comment on the IFR and 

the merits and claims of the petition. 

PHMSA will consider all public 

comments and address the petition for 

reconsideration in the final rule. 

DATES: The comment period for the 

interim final rule published on 

December 19, 2016 (81 FR 91860), is 

reopened. Comments must be received 

by November 20, 2017. 

ADDRESSES: You may submit comments 

identified by the docket number 

PHMSA–2016–0016 by any of the 

following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the online 

instructions for submitting comments. 

• Fax: 1–202–493–2251. 

• Mail: Hand Delivery: U.S. DOT 

Docket Management System, West 

Building Ground Floor, Room W12–140, 

1200 New Jersey Avenue SE., 

Washington, DC 20590–0001 between 

9:00 a.m. and 5:00 p.m., Monday 

through Friday, except Federal holidays. 

Instructions: If you submit your 

comments by mail, submit two copies. 

To receive confirmation that PHMSA 

received your comments, include a selfaddressed stamped postcard. 

Note: Comments are posted without 

changes or edits to http://

www.regulations.gov, including any personal 

information provided. There is a privacy 

statement published on http://

www.regulations.gov. 

Privacy Act Statement 

In accordance with 5 U.S.C. 553(c), 

DOT solicits comments from the public 

to better inform its rulemaking process. 

DOT posts these comments, without 

edit, including any personal information 

the commenter provides, to 

www.regulations.gov, as described in 

the system of records notice (DOT/ALL– 

14 FDMS), which can be reviewed at 

www.dot.gov/privacy. 

FOR FURTHER INFORMATION CONTACT: 

Byron Coy, Senior Technical Advisor, 

Pipeline Safety Policy and Programs, by 

telephone at 609–771–7810 or by email 

at byron.coy@dot.gov. 

SUPPLEMENTARY INFORMATION: In 

December 2016, PHMSA issued an 

interim final rule (IFR) titled: ‘‘Pipeline 

Safety: Underground Natural Gas 

Storage Facilities’’ (81 FR 91860). In the 

IFR, PHMSA established minimum 

federal safety standards for intrastate 

and interstate underground natural gas 

storage facilities under its regulatory 

authority at 49 U.S.C. 60101 and 60102 

and as directed by section 12 of the 

‘‘Protecting our Infrastructure of 

Pipelines and Enhancing Safety Act of 

2016.’’ On January 18, 2017, the 

American Gas Association, the 

American Petroleum Institute, the 

American Public Gas Association, and 

the Interstate Natural Gas Association of 

America (INGAA) jointly submitted a 

petition seeking reconsideration of 

certain provisions of the IFR. (INGAA 

has since withdrawn from the petition.) 

Recognizing that the IFR set certain 

deadlines by which the operators of 

underground natural gas storage 

facilities must act but that would occur 

before PHMSA could adopt a final rule, 

PHMSA published a notice on June 20, 

2017, in the Federal Register (82 FR 

28224), announcing that (1) the agency 

would not issue enforcement citations 

to operators for non-compliance with 

certain provisions of the IFR for a period 

of one year after publication of the final 

rule, and (2) it intended to address the 

issues raised by the petitioners in the 

final rule. For these reasons, PHMSA is 

now providing the public with an 

additional opportunity to comment on 

the IFR and an opportunity to comment 

on the issues raised in the petition. 

PHMSA is therefore reopening the 

comment period for this IFR until 

November 20, 2017. All documents and 

comments related to this matter are 

available for review at http://

www.regulations.gov in docket number 

PHMSA–2016–0016. 

Issued in Washington, DC, on October 11, 

2017, under authority delegated in 49 CFR 

1.97. 

Alan K. Mayberry, 

Associate Administrator for Pipeline Safety. 

[FR Doc. 2017–22553 Filed 10–18–17; 8:45 am] 

BILLING CODE 4910–60–P 


rmajette on DSKBCKNHB2PROD with RULES